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ABSTRACT  
   
X-ray diffraction is the technique of choice to determine the three-dimensional 
structures of proteins. In this study it has been applied to solve the structure of the 
survival motor neuron (SMN) proteins, the Fenna-Mathews-Olson (FMO) from 
Pelodictyon phaeum (Pld. phaeum) protein, and the synthetic ATP binding protein DX. 
Spinal muscular atrophy (SMA) is an autosomal recessive genetic disease 
resulting in muscle atrophy and paralysis via degeneration of motor neurons in the spinal 
cord. In this work, we used X-ray diffraction technique to solve the structures of the three 
variant of the of SMN protein, namely SMN 1-4, SMN-WT, and SMN-Δ7. The SMN 1-
4, SMN-WT, and SMN-Δ7 crystals were diffracted to 2.7 Å, 5.5 Å and 3.0 Å, 
respectively. The three-dimensional structures of the three SMN proteins have been 
solved. 
The FMO protein from Pld. phaeum is a water soluble protein that is embedded in 
the cytoplasmic membrane and serves as an energy transfer funnel between the 
chlorosome and the reaction center. The FMO crystal diffracted to 1.99Å resolution and 
the three-dimensional structure has been solved. 
In previous studies, double mutant, DX, protein was purified and crystallized in 
the presence of ATP (Simmons et al., 2010; Smith et al. 2007). DX is a synthetic ATP 
binding protein which resulting from a random selection of DNA library. In this study, 
DX protein was purified and crystallized without the presence of ATP to investigate the 
conformational change in DX structure. The crystals of DX were diffracted to 2.5 Å and 
the three-dimensional structure of DX has been solved. 
 
   ii 
DEDICATION 
   
Dedicated to my parents for giving me the love and support to succeed at my goals. I 
would never be where I am today without their encouragements. 
   iii 
ACKNOWLEDGMENTS  
   
I wish to thank Dr. James P. Allen and Dr. JoAnn C. Williams for given me the 
great opportunity as an undergraduate and graduate researcher to participate in research. I 
would like to thank Dr. Allen for given me a chance to learn about many paths in 
research and allowed me to work freely and develop the strategies as a graduate student. 
Finally, I wish to thank families and friends for their supports. 
   iv 
TABLE OF CONTENTS  
          Page 
LIST OF TABLES viii 
LIST OF FIGURES    ix 
CHAPTER 
1    An overview of x-ray crystallograpy ................................................................................ 1 
Introduction..................................................................................................... 1 
Basic concept of crystallization...................................................................... 2 
     Conditions affecting crystal growth .......................................................... 3 
Basic concept of X-ray diffraction ................................................................. 5 
     The unit cell ............................................................................................... 8 
Data collection and analysis ......................................................................... 11 
References..................................................................................................... 14 
2    INTRODUCTION TO SPINAL MUSCULAR ATROPHY......................................... 16 
Introduction................................................................................................... 16 
Classification of SMA .................................................................................. 16 
SMN protein ................................................................................................. 18 
References..................................................................................................... 24 
3    THREE-DIMENSIONAL STRUCTURE OF SURVIAL MOTOR NEURON (SMN) 
      PROTEIN : SMN 1-4.....................................................................................................  27 
Introduction................................................................................................... 27 
Materials and methods.................................................................................. 28 
     SMN 1-4 protein expression and purification......................................... 28 
   v 
Results........................................................................................................... 30 
     Crystallization.......................................................................................... 30 
     Data collection and analysis .................................................................... 31 
     Refinement............................................................................................... 32 
     Three-dimensional structure of SMN 1-4 ............................................... 33 
Discussion..................................................................................................... 35 
     Comparison of SMN Tudor domains...................................................... 35 
     Comparison of SMN Tudor domains to other proteins .......................... 36 
References..................................................................................................... 40 
4    THREE-DIMENSIONAL STRUCTUREs OF SURVIVAL MOTOR NEURON  
       (SMN) PROTEINS: SMN-WT AND SMN-Δ7...........................................................  43 
Introduction................................................................................................... 43 
Materials and methods.................................................................................. 45 
     SMN-WT and SMN-Δ7 protein expression and purification................. 45 
     Size exclusion chromatography (SEC) ................................................... 45 
Results and discussion.................................................................................. 45 
     Protein crystallization .............................................................................. 45 
     Data collection ......................................................................................... 47 
     Data analysis............................................................................................ 48 
     Refinement............................................................................................... 49 
     Three-dimensional structure of SMN- Δ7............................................... 50 
     Three-dimensional structure of SMN-WT.............................................. 52 
References..................................................................................................... 57 
   vi 
 
 
5    The three-dimensional STRUCTURE OF FMO PROTEIN  
      FROM Pelodictyon phaeum ..........................................................................................  59 
Introduction................................................................................................... 59 
Materials and methods.................................................................................. 61 
     Protein expression and purification......................................................... 61 
Results........................................................................................................... 62 
     Crystallization.......................................................................................... 62 
     Data collection and refinement................................................................ 62 
     Three-dimensional structure of the FMO protein from Pld. phaeum..... 64 
Discussion..................................................................................................... 69 
     Comparison of protein-BChl interactions in the three FMO structures . 73 
     Comparison of position and orientation of BChl 8 in the three  
     FMO structures ........................................................................................ 79 
     Implications for optical spectroscopy and energy transfer ..................... 80 
References..................................................................................................... 86 
6    THREE-DIMENSIONAL STRUCTURE OF Synthetic ATP  
      BINDING PROTEIN (DX) ...........................................................................................  90 
Introduction................................................................................................... 90 
Results and discussion.................................................................................. 91 
     Protein crystallization .............................................................................. 91 
     Data collection and analysis .................................................................... 92 
     Structure refinement ................................................................................ 93 
   vii 
     The three-dimensional structure of DX protein ...................................... 94 
References..................................................................................................... 96 
REFERENCES.....................................................................................................................  97 
   viii 
LIST OF TABLES 
Table       Page 
2.1       Classification of SMA ................................................................................... 17 
3. 1      Folding buffers ............................................................................................... 30 
3. 2      Summary of X-ray diffraction data and refinement of SMN 1-4 .................. 32 
3. 3      The organization of the residue ranges of each domain................................. 34 
4. 1      Summary of X-ray diffraction data and refinement of SMN-WT and  
            SMN-Δ7 .......................................................................................................... 50 
4. 2      Summary of secondary structure and domain arrangment of SMN-Δ7 ........ 52 
4. 3      Summary of secondary structure and domain arrangment of SMN-WT....... 55 
5. 1      Crystallographic data summary of FMO from Pld. phaeum ......................... 64 
6. 1      Summary of X-ray diffraction data and refinement of DX ........................... 94
   ix 
LIST OF FIGURES 
Figure               Page 
1. 1     Diffraction from one dimensional array of molecules ..................................... 7 
1. 2     Diffraction from crystallographic planes........................................................... 8 
1. 3     Bravais lattices ................................................................................................. 10 
2. 1     Genetic basis of SMA...................................................................................... 18 
2. 2     The known roles of the SMN protein .............................................................. 19 
2. 3     Schematic representation of the SMN complex.............................................. 20 
2. 4     Structure of the SMN Tudor domain .............................................................. 21 
2. 5     Partial SMN structure ..................................................................................... 22 
2. 6      The three-dimensional structure of MBP-YG box dimer ............................. 23 
3. 1     SMN 1-4 sequence........................................................................................... 28 
3. 2     Three-dimensional structure of SMN 1-4 protein ........................................... 33 
3. 3     Subunit A color-coded according to the encoded exon ................................. 34 
3. 4     Domains of subunit A of SMN 1-4 ................................................................. 35 
3. 5     Comparison of the Tudor domains .................................................................. 36 
3. 6     The comparison of SMN Tudor domain to Sm structures ............................. 37 
3. 7     Comparison of the three domains of SMN to several other protein 
            components ..................................................................................................... 38 
3. 8     Several missense mutations have been found in exons 1-4 in SMA  
           patients ............................................................................................................ 39 
4. 1     Localization of the nucleotides ....................................................................... 43 
4. 2     SMN-WT and SMN-Δ7 sequences ................................................................ 44 
   x 
4. 3      Image of SMN-Δ7 protein crystals ................................................................ 46 
4. 4      Image of X-ray diffraction of SMN-Δ7 ......................................................... 48 
4. 5      The three-dimensional structure of SMN-Δ7 ................................................ 51 
4. 6      Domains of SMN-Δ7 ...................................................................................... 52 
4. 7      The three-dimensional structure of SMN-WT .............................................. 53 
4. 8      The monomer of SMN-WT ........................................................................... 54 
4. 9      Comparison of SMN-WT domains ............................................................... 55 
4. 10    Comparison of C-terminal region of SMN-WT and SMN-Δ7 ...................... 56 
5. 1      The three-dimensional structure of FMO from Pld. phaeum ....................... 66 
5. 2      The interface between subunits of the trimer of FMO from Pld. phaeum ... 68 
5. 3      The three-dimensional structure of BChl cofactors of each subunit  
            of FMO from Pld. phaeum ............................................................................ 69 
5. 4      Strongly conserved regions for FMO proteins from different species .......... 72 
5. 5      Comparison of the structure of BChl 1 and nearby amino acid residues ...... 75 
5. 6      Comparison of the structure of BChl 5 and nearby amino acid residues ..... 78 
5. 7      Superposition of the old model and the new model of BChl 8 with  
            the omit electron density map ........................................................................ 80 
5. 8      Absorption and CD spectra of five FMO proteins ......................................... 82 
5. 9      Cofactor arrangement in FMO from Pld. phaeum with exciton couplings .. 84 
6. 1      Three-dimensional structure of 18-19 and DX proteins ................................ 91 
6. 2      Image of DX protein crystals.......................................................................... 92 
6. 3     Image of X-ray diffraction of DX protein ....................................................... 93 
6. 4     Three-dimensional structure of DX protein ................................................... 95
   1 
Chapter 1 
AN OVERVIEW OF X-RAY CRYSTALLOGRAPHY 
Introduction 
In this dissertation, X-ray diffraction is used to solve the three-dimensional 
structure of three different proteins, survival motor neuron (SMN) protein associated with 
spinal muscular atrophy (SMA), Fenna-Mathews-Olsen (FMO) a photosynthetic protein 
from Pelodictyon phaeum (Pld. phaeum), and the synthetic ATP-binding DX protein. 
This dissertation is comprised of six chapters. In Chapter 1, an overview of X-ray 
crystallography, the basic concept of X-ray diffraction is discussed based partially on a 
published paper (Allen et al., 2009). This chapter will present the concept of the X-ray 
crystallography technique used for solving three-dimensional structures of proteins. 
Chapter 2, introduction to spinal muscular atrophy (SMA), covers the basic 
understanding of SMA, comparison of the SMN protein to related structures of other 
proteins, and the roles of SMN in the cell. In Chapter 3, three-dimensional structure of 
SMN 1-4, the three-dimensional structure of SMN 1-4 is presented, including a 
comparison to the previously published SMN Tudor domain (Selenko et al., 2001; 
Sprangers et al., 2003). The model of SMN 1-4 was used for molecular replacement to 
solve the structure of SMN-WT and SMN-Δ7. In Chapter 4, three-dimensional structures 
of survival motor neuron (SMN) proteins, SMN-WT and SMN-Δ7, the three-dimensional 
structures of SMN-WT and SMN-Δ7 are described. The three-dimensional structure of 
the FMO protein from Pld. phaeum is described in Chapter 5 and the implication for 
energy transfer is discussed, which is covering material published in Photosynthesis 
Research (Larson et al., 2011). Also discussed are a modification of the structure as 
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presented in Tronrud and Allen, 2012. The three-dimensional structure of synthetic ATP 
binding protein (DX) will be discussed in Chapter 6, including protein crystallization, X-
ray diffraction, data analysis and three-dimensional structure.   
Multiple authors contributed to the published article (Allen et al., 2009) that 
serves as the basis of this chapter, and my contribution to this work was incorporation of 
X-ray diffraction figures and related text (Figures 1.3-1.5).  
Basic concept of crystallization 
X-ray crystallography is an excellent tool for visualizing protein structure at the 
atomic level, which enriches our understanding of protein function. To date, the Protein 
Data Bank (PDB) contains approximately 82,000-protein structures determined by X-ray 
crystallography. X-ray diffraction crystallography is one of the most common methods 
for obtaining detail structure of protein and their complexes such as protein-protein, 
cofactors and ligands. In addition to X-ray diffraction, many proteins of fewer than 200 
residues have been solved by nuclear magnetic resonance (NMR) in which provides a 
model of the molecule in solution, rather than in the crystalline state.  
The most common method used for protein crystallization is vapor diffusion in 
which a droplet with the lower concentration of crystallization components (protein and 
precipitant) is equilibrated against a reservoir solution of higher concentration in a closed 
container. It can be done by the hanging drop or sitting drop methods in crystallization 
plates of 24 or 96 wells. Hanging drop vapor diffusion uses a very small volume of the 
protein solution, 2 µl to 10 µl. Sometimes, the volume of the protein used can be 
increased up to 20 µl, depending on the surface tension of the protein solution. When the 
surface tension of the protein solution is very low, the sitting drop technique can be 
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substituted. In both cases, the reservoir should be filled with a precipitant solution with a 
volume of approximately 500 µl to 1 ml.  
Conditions affecting crystal growth 
There are many factors that influence the crystallization of proteins, such as purity 
of the protein, protein concentration, choice of buffers, pH, temperature and precipitants. 
Crystallization trials are repeated multiple times to obtain good quality crystals. The most 
important factor in crystallization is the purity of the protein, as impure protein will not 
yield suitable crystals. The impurity of the protein solution results in a decrease of crystal 
quality, because crystals are not well packed in a crystal lattice form; in other words, it is 
disordered. When the protein solution is not pure, micro-crystals are sometimes observed 
and maximum growth cannot be reached. Different batches of protein will have different 
purities, which affects crystal growth.  
Depending on types of buffer and the protein concentration, the quality of crystals 
can be varied. Slight changes in protein concentration or buffer affect the size and quality 
of the crystals (Rhodes, 2006). HEPES (4,2-hydroxyethyl-1-piperazineethansulfonic 
acid) or Tris (Tris hydroxymehtyl aminomethane) are the most common buffers used in 
crystallization. The pH is the most important determinant of protein solubility because 
proteins accumulate different charges at a different pH values (Bergfords, 1999). By 
changing of pH, it alters the ionization state of surface amino acid residues, which allows 
protein to contact and form crystals. Besides the buffer and pH, temperature is also 
another important parameter in crystallization process since it affects protein stability and 
solubility, which leads to crystal growth.  
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The concentration of precipitants plays an important role in the protein solubility 
(Papanikolau et al., 2004). Many precipitants can affect the protein solubility such as 
salts, polyethylene glycol (PEG), and organic solvents. The ionic strength of salt 
enhances the hydrophobic effects of the protein. Depending upon the nature of the 
particular cation and anion of the salts, it can maintain the solubility of the protein in the 
solution in which crystals may form.  The salt ions can participate in specific interactions 
with the protein molecules in the solution and result in crystal formation (Durbin and 
Feher, 1996). Depending on the nature of protein, ammonium sulfate, (NH4)2SO4, can 
also be used for protein crystallization. Control of pH should be taken into consideration 
when the (NH4)2SO4 salt is added, since the sulfate ions will change the pH of the protein 
solution. The isoelectric point, pI, of the protein can also be used as a starting point for 
the choice of pH and precipitants (Bergfords, 1999). At a certain pH, which is defined as 
the pI, the numbers of positive charges and negative charges on a protein are equal and 
the protein is electrically neutral (Rosenberg, 2004). 
When all conditions are set for the initial screen, possible additives should be 
tested. Possible additives are metal ions, chelators, low-molecular-weight organic 
compounds, detergents, and ligands (Wood, 1990). These additives have been found to 
improve the quality of the crystal growth in some cases. 
The process of nucleation is analogous to the process of condensation of droplets 
(Durbin and Feher, 1996). The nucleation could be homogenous or heterogeneous. 
Homogenous nucleation involves only association of the molecule itself. Favorable 
conditions and the formation of an amorphous aggregate are hard to achieve for protein 
crystallization, because protein behavior changes in different environments. 
   5 
Heterogeneous nucleation is involved in association of the protein to other substances. 
Heterogeneous nucleation is indicated when crystals tend to form on dust particles, fibers, 
or other visible objects. Therefore, prior filtration may significantly reduce the number of 
crystals (Durbin and Feher, 1996). When objects contact with protein molecules, the 
nucleation forms at the lower supersaturation level. Therefore, it poisons the surface of 
the crystal. Excessive crystal nucleation and growth rates often result in poor diffraction 
quality (Jovine, 2000). 
Basic concept of X-ray diffraction 
 X-ray diffraction has been used for 100 years to solve the structures of molecules. 
The first structures of proteins, myoglobin and hemoglobin, were solved over 50 years 
ago (Kendrew et al., 1960; Perutz et al., 1960). Diffraction is the technique of choice for 
the determination of the three-dimensional structures of proteins. The basic concept of 
diffraction can be understood by considering a simple array of molecules that are 
uniformly spaced in a line (Figure 1.1). When a wave impinges on the array, each 
molecule is assumed to simply scatter the wave, changing only the direction but not the 
energy of the wave. After scattering to a specific point at a large distance away from the 
array, the wave at that point will be the sum of all the scattered waves. In some cases, the 
waves will superimpose favorably while in other cases the waves will cancel. Consider 
the scattering from the neighboring molecules in which two scattered waves are identical 
except that one wave travels a longer distance Δ given by 
Δ = a sin θ   (1.1) 
where a is the spacing between the molecules, and θ is the angle between the incident 
wave and the scattered wave. When this path difference is equal to the wavelength, then 
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the waves add constructively. In general, a diffraction peak will be observed when the 
path difference is a multiple of the wavelength, or 
nλ = a sin θ,   (1.2) 
where n is an integer.  
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Figure 1.1. Diffraction from a one-dimensional array of molecules. Each 
molecule is spaced a distance a apart from the neighboring molecule. The 
incident wave is considered to scatter from each molecule to a point at a 
large distance D, with the scattered waves having different path lengths. 
At an angle θ, the path length difference between neighboring molecules is 
given by a sin θ. When the path length difference is equal to a multiple of 
the wavelength, the waves add constructively and a diffraction peak is 
observed. For simplicity, only four of the scattered waves are shown in the 
figure (Allen et al., 2009). 
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 For diffraction from a physical crystal, the scattering in three dimensions must be 
considered, although the analysis is essentially the same (Figure 1.2). The incident wave 
can be considered to strike a plane of atoms in the crystal. Diffraction is observed when 
the difference in the path length between the scattered waves from two adjacent planes, 
which is determined by the distance between the two planes, a, and the incident angle, θ, 
is equal to a multiple of the wavelength according to Bragg’s law: 
nλ = 2a sin θ,   (1.3) 
 
Figure 1.2. Diffraction from crystallographic planes. The crystal is 
considered to consist of a series of planes that can each scatter the incident 
wave. As was true for the one-dimensional array, the difference between 
the scattered waves is the difference in the path length between the 
neighboring planes, which equals 2a sin θ. When this path difference 
equals a multiple of the wavelength, the waves add constructively and a 
diffraction peak is observed (Allen et al., 2009). 
 
The unit cell  
 All crystals, including those made from proteins, are composed of molecules that 
are precisely arranged in three-dimensional arrays. The smallest building block of the 
crystal is known as the unit cell, and the crystal can be considered to be composed of 
   9 
great number of unit cells stacked next to each other. As originally studied in the 1800s 
by Bravais, the arrangement of unit cells can be classified according to the three lengths 
and angles associated with each unit cell and their symmetry relationship. The possible 
arrangements range from triclinic cells that have no symmetry to the highly symmetrical 
cubic cells (Figure 1.3). In some cases, the symmetry is simple. For example, cubic 
crystals have a fourfold symmetry along the directions of the edges and twofold 
symmetry along the diagonals. In other cases, the symmetry is more complexes; for 
example, unit cells can have a twofold screw axis in which each molecule is related to 
each other by the combination of a twofold rotation and a translation along the c axis. 
Protein crystals commonly have screw axes because the crystal packing is improved 
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Figure 1.3. Bravais lattices. Shown are the seven types of unit cells and the 
allowed unique lattices. The relationships among the three characteristic 
cell lengths, a, b, and c are shown as well as for the three angles, α, β, and 
γ. Also indicated are the symmetries for each cell type. Each cell type can 
have primitive (P), face-centered (C), body-centered (I), or all face- 
centered (F) cells. The dashed lines show that for these different cell types, 
there can be additional lattice points. The body-centered cells have an 
additional lattice point in the center (Allen et al., 2009). 
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Data collection and analysis 
 Once crystals have been obtained, X-ray diffraction measurements are performed 
using either an in-house facility or at a synchrotron. Laboratory instruments are useful for 
establishing the space group and measuring the initial data sets. However, for many 
proteins, the diffraction is weak requiring that the measurements use the much more 
intense X-ray beams available at synchrotrons. In either case, the crystals are aligned and 
exposed to the X-ray beam with the diffraction measurement in real time by an electronic 
detector. The space group can be immediately identified based on the arrangement of the 
diffraction peaks in the resulting images. The quality of the data is usually described by 
the resolution limit, which represents the largest angle from the beam that can be reliably 
measured. In order to solve any given structure, data to a resolution limit beyond 3 Å is 
required with smaller numerical values for the resolution limit representing data that is 
collected to larger angles, and hence is more complete. Crystals yielding data with 
smaller resolution limits represent more measured data and hence better data, with data 
beyond a resolution limit of 1 Å being rare for protein crystals. In addition to the 
resolution limit, there are other measures of the quality, with the crystals order being 
critical for many integral membrane proteins. Due to the presence of detergent molecules 
surrounding a significant portion of the protein, the interactions between the neighboring 
proteins are often limited resulting in relatively poorly ordered crystals. In terms of the 
diffraction, poorly ordered crystals are apparent by the measurement of diffraction spots 
that are not sharp but diffuse, with the resolution being restricted by the overlap of spots.  
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In order to determine the structure, it is necessary to measure the intensity of 
every diffraction spot. The specific space group determines the location of each 
diffraction peak, while the intensity is related to the composition of the unit cell. Since 
the data are recorded electronically, these measurements can be performed quickly. The 
difficulty in the interpretation lies in the nature of the diffraction as it is arising from 
complex rather than real terms. The diffraction can be considered to arise from the 
summation of vectors, called structure factors, which have both amplitude and phase, 
however, measurement of the intensity provides only the amplitude. Formally, in order to 
determine the structure, both are required in a Fourier series involving the summation of 
the structure factors, Fhkl, for all measured reflections, which are identified by the indices 
hkl  
€ 
ρ(x,y,z) = Fhkl e−2πi (hx+ky+ lz )
hkl
∑   (1.4) 
Notice that the summation yields not the position of the nuclei but rather , 
which is the density of electrons at a given point in space, since it is the electrons that 
scatter the X-rays. For this reason, the outcome of the data analysis is an electron density 
map into which a structural model, consisting of amino acid residues, must fit.  
Several experimental approaches can be used to solve the phase problem. The 
first approach, multiple anomalous dispersion, MAD, involves measurements at several 
wavelengths around the transition energy for a metal bound to the protein. Since the 
transition energy for each metal is very specific, the differences in the measured 
diffraction arise only due a specific metal resulting in contribution that arises only from 
the electrons in that metal. Once this metal is located, then an initial set of phases can be 
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estimated and a model can be built. In the second approach MIR (multiple isomorphous 
replacement) a metal is incorporated into the protein and the diffraction is compared to 
the protein without the metal. In this case, measurements of the diffraction from the 
crystals with different bound metals are needed to give accurate estimations of the 
phases. The last approach, molecular replacement, MR, can be utilized to solve the 
structures. In this case, there must be an existing structure that is highly homologous to 
the unknown structure. Essentially, the homologous structure is virtually rotated and 
translated in the unit cell until the orientation and position match those of the protein in 
the crystal.  
These approaches provide the means for generating the phases for the diffraction 
data and allowing the electron density to be calculated using Eq. 1.4. The outcome is a 
map of the electron density that is usually contoured at a level significantly above the 
background. Fitting of the maps involves identifying the atoms that give rise to each 
region of the density. While this is often manually done on a graphics terminal by a 
crystallographer, increasingly, the analysis of electron density maps is being performed 
directly by sophisticated programs. Once the native structure has been determined, 
structural modifications by mutagenesis or biochemical techniques can be rapidly 
identified provided the structural differences are small.  
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Chapter 2 
INTRODUCTION TO SPINAL MUSCULAR ATROPHY 
Introduction 
Spinal muscular atrophy, SMA, is an autosomal recessive disease characterized 
by degenerative disorder of anterior horn cells of the spinal cord (Lefebvre et al., 1995, 
Wirth, 2000). SMA causes child death in 1 in 6,000 to 10,000 live-births (Lefebvre et al., 
1995; Lorson et al., 1999) and is the second leading cause in the death of young children 
after cystic fibrosis (Wirth, 2000). There are three common types of SMA ranging from 
severe to mild forms (Alia et al., 2009) dependent upon the number of copies of the 
survival motor neuron (SMN1) gene. The survival of motor neuron (SMN) gene is located 
at position q13 of the chromosome 5 (Young et al., 2003). There are two copies of the 
SMN gene, SMN1 (telomeric copy) and SMN2 (centromic copy), which are almost 
identical, except a single nucleotide change from C to T in the SMN2 gene that causes an 
alternation of exon 7 splicing resulting in SMA (Lefebvre et al., 1995; Wang and 
Dreyfuss, 2004; Young et al., 2003). This exon skipping event leads to a lower cellular 
functionality; however, it only affects the anterior horn cells of the spinal cord. 
Approximately 95% of SMA patients are found to have the SMN 1 gene absent (Burghes, 
1997; Clermont et al., 1997, Fischer et al., 1999; Lefebvre et al., 1995; Young et al., 
2003). Depending upon the arrangement of the SMN genes, SMA can be ranged from 
acute to mild forms. 
Classification of SMA 
In 1991, the International SMA Consortium classified three common clinical 
types of SMA (Table 2.1) (Munsat, 1991; Nicole et al., 2002; Wirth, 2000). The absence 
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of the SMN1 gene causes the severity of SMA. In SMA type I patients, SMN1 gene are 
lost or mutation while the SMN2 gene remains. Type I, namely Werdnig-Hoffmann 
disease, the most lethal form of SMA. It is characterized by severe, generalized muscle 
weakness and hypotonia at birth or within the next 6 months (Nicole et al., 2002). Type I 
patients are unable to sit, stand or walk, and many have respiratory problems. Usually, 
death occurs within two years of age by respiratory failure (Lefebvre et al., 1995). The 
homozygous deletion of the SMN1 gene with an extra copy of the SMN2 gene appears in 
a majority of type II SMA, which is an intermediate form. Type II patients are able to sit 
but never gain the ability to stand or walk without assistance (Nicole et al., 2002). The 
life expectancy of those with type II SMA is between two and four years. In a majority of 
type III SMA patients, two extra copies of the SMN2 gene are present. Type III, also 
known as Kugelberg-Welander disease, is the less severe form of SMA. Patients carrying 
type III have proximal muscle weakness (Lefebvre et al., 1995; Nicole et al., 2002). 
Symptoms may appear between two and 17 years of age. Patients are able to walk during 
the early stages, but require the support of a wheelchair during adulthood. Death may 
occur in early adulthood for those with type III SMA.   
Table 2.1. Classification of SMA  
Type    Age of onset    Function         Age of occurrence/death 
I  at birth-6 months never sit   < 2 
II  < 18 months  able to sit, never stand > 2 
III  > 18 months  stand alone   Adult 
Table adapted from Munsat, 1991 
As shown in Figure 2.1, the transcription of SMN1 is mainly produced as the full-
length form whereas SMN2 is transcribed into both the full-length and the truncated form 
lacking exon 7, SMN-Δ7. The truncated form is found most abundant in SMA patient and 
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correlated to the disease severity (Young et al., 2003). The SMN2 gene produces mostly 
unstable proteins, which are degraded rapidly and expressed in very small amount of 
stable proteins. 
 
Figure 2.1. Genetic basis of SMA. The SMN1 and SMN2 are identical 
except the single-nucleotide change in exon 7 (C to T). SMN1 is produced 
a normal protein whereas SMN2 is produced low SMN protein and 
truncated form lacking exon 7, leading to unstable protein that is degraded 
rapidly (Burghes and Beattice, 2009). 
 
SMN protein 
The SMN gene encodes a protein of 294 amino acids that has a molecular weight 
of 38 kDa (Malatesta et al., 2004). SMN forms high molecular weight complexes in the 
cytoplasm and nucleus of the cell (Pellizzoni et al., 1999) (Figure 2.2). In the cytoplasm, 
SMN interacts with Sm proteins, which assist in the formation of the Sm core and helps 
the assembly of the small nuclear ribonucleoproteins (snRNPs) for nuclear transport 
(Zhang et al., 2011). Sm proteins are termed because of their reactivity with 
autoantibodies of the Sm serotype from patients with systemic lupus erythematosus 
(MacKenzie and Gendon, 2001). With lesser amounts of SMN present within the cell, the 
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Sm core is not formed resulting in limited of snRNP processing and failure to assemble 
the snRNPs (Gabanella et al., 2007; Pellizzoni et al., 1999). In the nucleus, SMN 
complex plays an important role in the pre-mRNA splicing. Once the uridine (U) small 
nuclear RNA (snRNA), U1, U2, U4, U5 and U6 enter the nucleus, the SMN protein 
assembled the snRNPs for the pre-RNA splicing. Significantly, the impairment of SMN 
function in Sm core formation causes decreasing levels of a subset of snRNPs (Gabanella 
et al., 2007). In SMA patients, the SMN-Δ7 protein is found to have less effective 
binding with the snRNPs complex than the SMN-WT. 
 
 
Figure 2.2. The known roles of the SMN protein: cytoplasmic assembly of 
the core snRNP complex; nuclear regeneration/reactivation of snRNPs 
involved in pre-mRNA splicing; and direct and indirect transcriptional 
activation (MacKenzie and Gendon, 2001). 
 
SMN interacts with the Gemin proteins forming the SMN complex and highly 
enriched in structures termed gems (Gemini of coiled bodies) (Gubitz et al., 2004). SMN 
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has been found to directly interact with Gemin2, Gemin3, Gemin5, and Gemin7, and 
indirectly interact with Gemin4 and Gemin6. Association of Gemin4 and Gemin6 with 
the SMN protein is through the association of Gemin3 and Gemin7, respectively (Figure 
2.3). Gemin2, which was formerly known as SMN interacting protein 1 (SIP1), was 
identified as a core component of the SMN complex (Ogawa et al., 2007; Wang and 
Dreyfuss, 2001). Recent studies have found that Gemin2 plays an essential role in 
snRNPs assembly through the stabilization of the SMN oligomer/complex via novel self-
interaction (Ogawa et al., 2007; Shpargel and Matera, 2005). Gemin2 and Gemin3 
degrade when the amount of SMN is reduced. Furthermore, another study found that the 
SMN complex lacking Gemin5 fails to promote uridine-rich (U) snRNP assembly (Otter 
et al., 2007).  
 
 
Figure 2.3. Schematic representation of the SMN complex. For simplicity, 
the SMN complex is illustrated in dimeric form (Gubitz et al., 2004). 
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The overall three-dimensional structure of SMN protein remains unknown with 
the exception of the Tudor domain, a short helix that binds to Gemin2, and a tyrosine-
glycine-rich (YG box) region near the C-terminal region. The structure of the Tudor 
domain was solved by using X-ray crystallography (PDB:1MHN) (Sprangers et al., 2003) 
and NMR (PDB:1G5V) (Selenko et al., 2001). The SMN Tudor domain consists of 5 
strongly bent anti-parallel β-barrels (Figure 2.4). This domain consists of amino acid 
residues 92-144 of the SMN protein and is largely encoded by exon 3 of the SMN gene 
(Buhler et al., 1999; Selenko et al., 2001; Sprangers et al., 2003).  
 
Figure 2.4. Structure of the SMN Tudor domain. a) The five strands form 
a barrel-like fold that is lined at the bottom by the long curved β2 strand 
and closed by anti-parallel interaction between β1 and Leu 12 in the short 
β5 strand. Strands β1-4 are connected by short turns, while strands β4 and 
β5 are linked by a helical turn. b) The formation of a hydrophobic core 
stabilizes the structure by highly conserved amino acid residues (Cys 98, 
Ala 100, Ala 111, Ile 113, Ile 116, Cys 123, Val 125, and Leu 141) 
(Selenko et al., 2001). 
 
The Tudor domain facilitates SMN interactions in complexes with Sm proteins 
and snRNPs. The glutamic acid residue, position 134 (E134) of the β4 strand of the 
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Tudor domain interacts with the Sm protein at the C-terminus. A SMA-causing point 
mutation, glutamic acid to lysine at the position 134 (E134K), within the SMN Tudor 
domain prevents Sm binding (Selenko et al., 2001; Sprangers et al., 2003). The mutation 
does not specifically alter the Sm binding site; however, it changes the overall structure 
of the SMN (Buhler et al., 1999). The mutation of this single amino acid residue results 
in a change in the charge distribution affecting the electrostatic interactions with the 
positively-charged C-terminal Sm tails (Selenko et al., 2001; Sprangers et al., 2003).  
Recently, the SMNGe2BD was crystallized as fusion product with Gemin2 and Sm 
pentamer complex (Zhang et al., 2011). The three-dimensional structure of the Gemin2-
SMNGe2BD-Sm pentamer complex has been solved using X-ray (PDB:3S6N) (Zhang et 
al., 2011) and NMR (PDB:2LEH) (Sarachan et al., 2012). SMNGe2BD is an N-terminal 
region of SMN, the residue range 37 to 51. This small section of the SMN structure forms 
a helix that interacts with Gemin2 (Figure 2.5).  
 
 
Figure 2.5. Partial SMN structure. a). Helix of N-terminal region, residues 
37 to 51, of SMN that bind to Gemin2. b). SMN (blue) interaction with 
Gemin2 with five Sm proteins (Zhang et al., 2011). 
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The tyrosine-glycine rich, YG, region of SMN was crystallized as a fusion 
product with the maltose binding protein, MBP (Martin et al., 2012). The three-
dimensional structure of the C-terminal YG region, containing residues ranging from 263 
to 294 has been solved (Martin et al., 2012). The YG region forms a helix and interacts 
with each other to form a dimer (Figure 2.6). 
 
Figure 2.6. The three-dimensional structure of Maltose binding protein-
tyrosine-glycine, MBP-YG, box dimer. MBP is shown in gray and the YG 
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Chapter 3 
THE THREE-DIMENSIONAL STRUCTURE OF SURVIVAL MOTOR NEURON 
(SMN) PROTEIN: SMN 1-4 
Introduction 
It has been shown that SMA patients contain mostly the SMN-Δ7 protein with a 
small amount of the SMN-WT protein (previously explained in Chapter 2). The SMN-
WT proteins are degraded rapidly in the cell whereas SMN-Δ7 proteins still remain. The 
SMN-Δ7 protein cannot compensate the loss SMN-WT, which results in loss of function 
and affects the cellular function in the spinal cord found in SMA patients. The SMN-WT 
protein was known to have a self-association (Burhler et al., 1999; Burghes and Beattie, 
2009) of which the truncated form would reduce the SMN-SMN interaction. To 
investigate this, we constructed a truncated form of SMN, which encoded exon 1-4, 
namely SMN 1-4, was created to reduce the SMN-SMN association. The SMN 1-4 
construct consists of 209 amino acid residues (Figure 3.1) and this construct was created 
to assist in purification, crystallization and determination of the three-dimensional 
structure of SMN-WT and SMN-Δ7.  
We have determined the three-dimensional structure of the SMN 1-4 at a 
resolution limit of 2.7 Å with Rwork and Rfree value of 27.96% and 30.91%, respectively. 
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Figure 3.1 SMN 1-4 sequence. The fusion His-tag at the N-terminal of the 
sequence is shown in blue. 
 
 My contribution to this Chapter was solving the three-dimensional structure of 
SMN 1-4 that was obtained using crystallographic data from Dr. Craig Magee. The three-
dimensional structure of SMN 1-4 was used for molecular replacement to solve the three-
dimensional structures of SMN-WT and SMN-Δ7. All SMN clones were obtained from 
the laboratory of Chistian L. Lorson at the University of Missouri-Columbia, in 
Columbia, Missouri. 
Materials and methods 
SMN 1-4 protein expression and purification 
The methods of SMN 1-4 protein expression, purification, and crystallization 
were adapted from Dr. Craig L. Magee (Magee, 2006). The SMN 1-4 gene was cloned 
into the pRSET vector with His6 tag at the N-terminal region and overexpressed in 
Escherichia coli, E.coli, BL21 (DE3) cells. The cells were grown in super optimal broth 
(SOB) media at 37 ºC and induced with 1 mM isopropyl β-thiogalactoside (IPTG) when 
OD600 reached 0.6 - 0.9. Following an additional 4 hours of growth, bacteria cells were 
harvested by gravimetric centrifugation at 4ºC and 6,000 rpm for 10 minutes, and stored 
at -20 ºC. The cell pellet was approximately 10-15 grams per liter of growth media. 
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Then cell pellet was re-suspended in 10 ml of cold phosphate buffer saline (PBS) 
containing 140 mM NaCl, 2.7 mM potassium chloride (KCl), 10 mM sodium phosphate 
dibasic (Na2HPO4), 1.8 mM potassium phosphate monobasic (KH2PO4), pH 7.3, at 4 ºC 
overnight. Cells were lysed by sonication in the presence of 0.2 mg/ml lysozyme, 25 
µg/ml DNase(I), 1 mM magnesium chloride (MgCl2), and 1% v/v of Triton X-100 
detergent. The lysate was clarified by centrifugation at 4 ºC and 13,000 rpm for 30 
minutes in a KA-21.5 rotor (Kompsin) using a RC2-B automatic refrigerated centrifuge 
(Sorvall).  
The inclusion body (IB) was re-suspended overnight at 4ºC in denaturing buffer 
containing 8 M urea, 0.095 M Na2HPO4, 0.005 M NaH2PO4, 0.5 M NaCl, 1 mM 
imidazole, 5 mM β-mercaptoethanol (BME) at pH 8.0 to solubilize SMN 1-4. Then the 
sample was clarified by centrifugation at 4ºC and 13,000 rpm for 30 minutes. The 
supernatant containing denature SMN 1-4 protein was purified by Ni affinity 
chromatography using fast flow Ni sepharose (Bioscience). The column was washed 
three times column volume with the denaturing buffer. The protein was eluted with 
elution buffer containing 8 M urea, 0.095 M Na2HPO4, 0.005 M NaH2PO4, 0.5 M NaCl, 
250 mM imidazole, 5 mM BME at pH 8.0.  
A purified SMN 1-4 was dialyzed against folding buffer A (Table 3.1) at 4ºC 
overnight using a 10 K MWCO SpectraPor 2 dialysis membrane. The SMN 1-4 proteins 
were concentrated using a 10 K MWCO Amicon ultrafiltration device (Millipore). The 
protein concentration was determined by UV/Vis spectroscopy at 280 nm using molar 
extinction coefficients, ε= 28,480 cm-1 M-1.  
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The SMN 1-4 protein was re-folded on a fast flow Ni sepharose (Bioscience) 
Omnifit FPLC column equipped with Pharmacia LKB FPLC (Fine Pressure Liquid 
Chromatography) system. The flow rate was set at 1 ml/min. The column was washed 
with buffer A (Table 3.1) to remove any aggregation or unbound SMN 1-4 protein. Then, 
the SMN 1-4 protein was folded in buffer B and eluted with buffer C (Table 3.1). The re-
folded SMN 1-4 protein was dialyzed using a 10 K MWCO SpectraPor 2 dialysis 
membrane in dialysis buffer containing 0.095 M Na2HPO4, 0.005 M NaH2PO4, pH 8.0, 
0.25 M NaCl, 1 mM BME, at 4ºC overnight. The folded SMN 1-4 protein was 
concentrated using a 10 K MWCO Microcon ultra-filtration device (Millipore). The 
protein concentration was determined by UV/Vis spectroscopy at 280 nm using molar 
extinction coefficients of ε= 28,480 cm-1 M-1. The yield of pure folded SMN 1-4 protein 
obtained from a 1 L culture was approximately 4-6 mg. The SMN 1-4 protein was 
concentrated to approximately 15-20 mg/ml for crystallization. 
Table 3.1. Buffers used for re-folding at pH 8.0 
 Buffer A Buffer B Buffer C 
Urea 6 M   
Sucrose  0.5 M  
Na2HPO4/NaH2PO4 0.095/0.005 M 0.095/0.005 M 0.095/0.005 M 
NaCl 0.5 M 0.5 M 0.5 M 
Imidazole 1 mM 1 mM 250 mM 
BME 1 mM 10 mM 1 mM 
Results 
Crystallization 
The SMN 1-4 protein was crystallized by the vapor diffusion technique using a 
hanging drop. Optimized protein crystallization conditions were resulted from the initial 
screens from Hampton search (HR1 and HR2). Briefly, droplets were prepared as 
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following 1 µl of the SMN 1-4 protein at 15 mg/ml were mixed with an equivalent 
volume of reservoir solution containing 50% v/v PEG 4,000, 100 mM Tris-HCl and 300 
mM NaCl at pH 8.0. The SMN 1-4 protein crystals appeared within 3 to 4 weeks with 
dimensions approximately 50 to 100 microns x 20 microns x 30 microns. The SMN 1-4 
protein crystallization and data collection were done by Dr. Craig L. Magee. 
Data collection and analysis  
Protein crystal measurements were performed at Arizona State University X-ray 
diffraction facility using the Rigaku R-AXIS IV++ detector at a wavelength of 1.54 Å. 
Diffraction data were indexed, refined, and integrated using crystal clear software 1.3.5 
(Rigaku-MSC) and scaled using SCALA (CCP4). Data analysis Phaser 1.3.1 was used 
for the molecular replacement based on the SMN Tudor domain (PDB ID: 1MHN) as a 
search model (Selenko et al., 2001; Sprangers et al., 2003). SMN 1-4 crystals diffracted 
to a resolution limit of 2.7 Å with the space group P21 with cell dimensions a=55.05 Å, 
b=49.38 Å, c=68.23 Å along with angles α= 90°, β=120° and γ=90°. Total and unique 
reflections were 53,732 and 4,201, respectively.  Rmerge was 15.80% with 100% 
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Table 3.2.  Summary of X-ray diffraction data and refinement of SMN 1-4 
Space group P21 
Resolution limits (Å) 2.7   
Unit Cell (Å)    a= 55.05, b=49.38, c= 68.23  
Angle (°) α=90, β=120, γ=90 
Reflections: 
 Total 53,732 
Unique   4,201 
Multiplicity 4.32  (4.03) 
I/σ (I) 6.4 (3.5) 
RMerge(%) 15.80 (35.40)  
Completeness (%) 100 (100) 
Refinement 
Rwork (%)/Rfree (%) 27.96 /30.91 
Number in asymmetric unit 1    
RMSD Bond length (Å)  0.013 
RMSD Bond angle (°)   2.402    
Ramachandran plots 
 Preferred (%)   78.60 
 Allowed (%)   16.10 
 Outlier (%)     5.40 
R-factor =Σ| |Fobs| -|Fcal||/ Σ |Fobs|, Free R-factor was calculated with setting aside 5% of 
the reflection data. Rmerge = ΣhklΣj |Ij(hkl) – [I(hkl)] | ΣhklΣj[I(hkl)] where Ij(hkl)is the 
intensity reflection, and I(hkl)is the mean intensity of symmetry related h, k, l. 
Number in the parenthesis is the outer shell value. 
Refinement 
The SMN 1-4 structure was manually built using COOT (Crystallographic 
Object-Oriented Toolkit) (Emsley and Cowtant, 2004) and refined using PHENIX (Adam 
et al., 2010). The residues 1-88 and 148-209 of SMN 1-4, which are not part of the Tudor 
domain (residues 89-147), have been built in SMN 1-4. 
The completed SMN 1-4 protein structure had Rwork and Rfree values of 27.96% 
and 30.91%, respectively (Table 3.2). Ramachandran plot values of the structure were 
78.60%, 16.10% and 5.40% in the preferred, allowed and outlier, respectively. Root 
mean square deviation (RMSD) bond length and bond angle were 0.013 Å and 2.402º, 
   33 
respectively. Procheck and Sfcheck were also used to verify the protein structure with the 
diffraction data and structural model (Laskowski et al., 1993 and Vaguine et al., 1999).  
Three-dimensional structure of SMN 1-4 
The SMN 1-4 structure consists of two subunits, A (green) and B (yellow), in the 
asymmetric unit (Figure 3.2). The A and B subunits are approximately related by a 2-fold 
symmetry axis. Loop regions of each subunit of SMN 1-4 expose the outer part of the 
structure (Figure 3.2). These loop regions of the two subunits are exposed to the surface 
area of the structure whereas the β-strands of the two subunits are facing each other. 
 
  
Figure 3.2.  Three-dimensional structure of the SMN 1-4 protein showing 
two subunits, identified as the A (lime green) and B (yellow) subunits.  
 
Each subunit consists of five encoded exons. The encoded exon, 1, 2a, 2b, 3, and 
4 is color-coded in yellow, orange, green, red and purple, respectively (Figure 3.3).  








Figure 3.3. Subunit A color-coded according to the encoded exon: exon 1, 
2a, 2b, 3, and 4 are in yellow, orange, green, red and purple, respectively. 
 
Each subunit consists of three domains, A1, A2, and A3 with residue ranges 41-67, 
89-147, and 151-201 respectively (Table 3.3). A1 consists of three β-strands whereas A2 
and A3 both consist of four long bent β-strands and a short helix (Figure 3.4). All 
domains have similar β-strand folding. The three β-strands of domain A1 form a β-sheet 
with a similar fold as domain A2.  
Table 3.3. The organization of the residue ranges of each domain 
Domain Residue range Secondary Structure 
A1 41-67 Three antiparallel β-sheets  
A2 89-147 Four antiparallel β-sheets and a 
short α-helix 
A3 151-201 Two long and two short 
antiparallel β-sheets and a short α-
helix 
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Figure 3.4. Domains of subunit A of SMN 1-4. Each subunit consists of 
three domains, which is the A subunit are termed A1 (orange), A2 (red), 
and A3 (purple) and shown separately for comparison. The three domains 
all have Sm-like folds: a) The A1 domain contains three anti-parallel β-
strands, b) The A2 domain (the Tudor Domain) consists of four anti-
parallel β-strands and a short helix, and c) The A3 domain contains four 
anti-parallel β-strands and one short α-helix.   
 
Discussion 
Comparison of SMN Tudor domains 
Subunits A2 and B2 (Figure 3.5a,b) have been determined independently from the 
SMN Tudor domain (Figure 3.5c) that had been solved by Selenko et al., 2001 and 
Sprangers et al., 2003. All three domains have similar folding and consist of four β-
strands.  However, a small difference from all three Tudor domains is that domain B2 has 
short β-strands which is caused by the disorder in the B subunit of the SMN 1-4 due to 
the crystallographic contacts.  
The three domains are very similar as expected, largely consisting of four β-
strands.  Small differences are found in the length of the β-strands, which presumably 
reflect the presence of the flanking protein regions in the SMN 1-4 structure and a 
disorder in this region of the B chain due to crystallographic contacts. 
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Figure 3.5. Comparison of the Tudor domains in: a). Subunit A2 (red), b). B2 
(blue) (solved by this work), and as solved as an independent construction in c). 
(sand) by Sprangers and colleagues (2003).   
Comparison of SMN Tudor domain to other proteins 
The SMN protein is known to express ubiquitously in the cell and has an essential 
role in RNA processing. The SMN complex assists in the formation of the seven-core Sm 
protein in the cytoplasm (Zhang et al., 2011). Subunit A2 of SMN 1-4 has a similar fold 
as the Sm protein except for the presence of an α-helix at the N-terminus or C-terminus 
of the Sm protein (Figure 3.6). The A2 domain consists of four long β-strands and a short 
α-helix at the C-terminal region whereas Sm D1 (Figure 3.6b) has one long β-strand and 
five short β-strands and a helix-turn-helix at the C-terminal region. Even though the 
number of β-strands in Sm D1 is more than in the A2 domain, both SMN and Sm D1 
shown to have the same fold, which is bent like a shell. The Sm D2 (Figure 3.6c) also has 
similar fold as the A2 domain except the long α-helix at the N-terminal region found in 
Sm D2 whereas the A2 domain has only a short α-helix at the C-terminal region.  
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Figure 3.6. The comparison of a). SMN Tudor domain (red) to Sm 
structures b). SmD1 (green) and c. SmD2 (orange) (Kambach et al., 1999). 
 
The SMN protein has interactions with the Gemin proteins (Gubitz et al., 2004). 
Gemin6 and Gemin7 are largely β-proteins with Sm-like folds consisting of several β 
strands.  In addition to the central β-sheet arrangement, the proteins have one or two 
helices near their N or C terminal regions.  The SMN A2 domain (Figure 3.7a) has a 
similar β-strands fold to Gemin6 and Gemin7 (Figure 3.7b,c). However, the A2 domain 
has a short α-helix at the C-terminus whereas Gemin6 has a helix at the C-terminus and a 
helix-turn-helix at the N-terminus and Gemin7 has a long α-helix at the N-terminal 
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Figure 3.7. Comparison of the three domains of SMN to several other 
protein components shows a significant structural homology. Shown are 
the structures of : a) The SMN Tudor domain (red) (this work) and b) 
Gemin6 (magenta), and c) Gemin7 (cyan), (Ma et al., 2005).  
 
In SMA patients, a number of missense mutations are found in exons 1 thru 4 
(Sun et al., 2005). The mutation sites are not localized on one side of the structure, but 
spread throughout the structure of the SMN 1-4 (Figure 3.8).  In some cases, the 
mutations occur for residues found on the surface of the proteins, for example Asp30, 
Asp44, and Gly95, and presumably the mutations interfere with binding to other proteins. 
Mutation of Gly95 and Ala111 result in reduce of binding of SMN to Sm protein and 
mutation of Asp30 and Asp 44 mutations perhaps affect the self oligomerization that lead 
to the loss of the binding ability Gemin2 (Liu et al., 1997; Sun et al., 2005). Gemin2 has 
strong binding with the SMN protein and is known to play an essential role in snRNPs 
assembly through the stabilization of the SMN complex via self-oligomerization (Otter 
et.al, 2007; Ogawa et al., 2007). For the A2G mutation, this amino acid residue is part of 
a loop that interacts with other regions and the mutation may destabilize this region of the 
protein.  
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Figure 3.8. Missense mutations have been found in exons 1-4 in SMA 
patients (Sun et al., 2005).  
 
The three-dimensional structure of the SMN 1-4 has been solved, but to gain an 
understanding at the molecular level of what leads to SMA requires the determination of 
the structures of SMN-WT and SMN-Δ7. The SMN 1-4 is 2/3 of the SMN-Δ7 and the 
final refinement of the SMN 1-4 model was sufficient for molecular replacement to solve 
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Chapter 4 
THREE-DIMENSIONAL STRUCTURES OF SURVIVAL MOTOR NEURON (SMN) 
PROTEINS: SMN-WT AND SMN-Δ7 
Introduction 
The SMN1 and the SMN2 genes consist of nine exons (1, 2a, 2b, 3, 4, 5, 6, 7, 8) 
and both genes are almost identical, except for five different nucleotides, which are 
located from intron 6 to exon 8 (Figure 4.1). A single nucleotide change from C to T in 
exon 7, between the SMN1 gene and the SMN2 gene causes the alternate splicing in exon 
7 in the SMN2 gene forming a truncated phenotype called SMN-Δ7 (Lorson et al., 1998; 
Lorson and Androphy, 2000). SMA patients have predominantly resulting the SMN-Δ7 
form of protein rather than the full-length form, SMN-WT.  
 
Figure 4.1. Localization of the nucleotides by which SMN1 can be 
distinguished from SMN2 (Wirth, 2000). 
 
The SMN-WT protein consists of 294 amino acid residues and SMN-Δ7 consists 
of 282 amino acid residues (Figure 4.2). Both SMN-WT and SMN-Δ7 have been 
crystallized and the structures have been solved. The three-dimensional structure of SMN 
1-4, described in Chapter 3, has been used as a search model to solve the structure of both 
SMN-WT and SMN-Δ7.  The residues, 205 to 294 of SMN-WT and 205 to 282 of SMN-
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Δ7, which are not part of the SMN 1-4 model, have been built in SMN-WT and SMN-Δ7, 
respectively. The completed three-dimensional structure of the SMN protein assists in 
understanding the cause of SMA and role of SMN in the cell. 
 
Figure 4.2. SMN-WT and SMN-Δ7 sequences. The SMN-WT sequence 
consists of a fusion tag (Blue) at the N-terminus and full length SMN and 
exon 7 shown in green. The SMN-Δ7 sequence consists of a fusion tag at 
the N-terminus, SMN lacking the region encoded by exon 7 and four 
amino acid residues from exon 8 shown in red.  
My contributions to this chapter are the expression, purification, folding, 
crystallization, and solving structure of SMN-Δ7 using molecular replacement from the 
three-dimensional structure of SMN 1-4. Once the three-dimensional structure of SMN-
Δ7 was completed, its structure was used for molecular replacement to solve the three-
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dimensional structure of SMN-WT, using the crystallographic data from Dr. Craig 
Magee. 
Materials and Methods 
SMN-WT and SMN-Δ7 protein expression and purification 
SMN-WT and SMN-Δ7 gene was cloned into an E.coli pRSET BL21 (DE3) over-
expression system with a His6 fusion tag at the N-terminal region. The SMN-WT and 
SMN-Δ7 cell culture, cell lysis, purification and folding was followed the SMN 1-4 
procedure as describe in Chapter 3. 
Size exclusion chromatography (SEC) 
The folded SMN-WT and SMN-Δ7 in a 0.1 M Tris-HCl pH 8.0, 250 mM NaCl 
was purified using a gel filtration chromatography Speharose CL-6B (GE healthcare). 
The purified SMN-WT was concentrated using a 10 K microcon ultra-filtration device 
(Millipore). The SMN-WT and SMN-Δ7 protein concentration was determined by 
UV/Vis spectroscopy at 280 nm using molar extinction coefficients, ε = 45,340 cm-1 M-1 
and ε = 45,220 cm-1 M-1, respectively. The yield of purified folded SMN-WT and SMN-
Δ7 protein obtained from a 1 L culture was approximately 2-3 mg and 4-6 mg, 
respectively.  
Results and Discussion 
Protein crystallization 
The hanging drop vapor diffusion method was used to crystallize SMN-WT. The 
SMN-WT crystallization initially was screened with Hampton Research grid screen 1 and 
grid screen 2 (HR1 and HR2), and the SMN 1-4 crystallization conditions. The initial 
conditions with SMN 1-4 crystallization conditions was not yield any crystals; however, 
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SMN-WT crystals were obtained using condition #25 of the Hampton Research grid 
screen 2 (HR2). The SMN-WT protein was concentrated to approximately 30 mg/ml in 
0.1 M Tris-HCl pH 8.0, 250 mM NaCl. The protein crystallization drop with a volume 1 
µl was combined with an equivalent volume of reservoir solution containing 1.8 M 
ammonium sulfate, 0.1 M MES pH 6.5 and 0.01 M cobalt chloride. 
The SMN-Δ7 protein was crystallized using the hanging drop vapor diffusion 
technique. The initial conditions were based upon the SMN-WT crystallization. The 
initial conditions yielded micro crystals and after optimizing the conditions, larger 
crystals were produced. The SMN-Δ7 protein was concentrated to approximately 36 
mg/ml in 0.1 M Tris-HCl pH 8.0, 250 mM NaCl. The protein crystallization drop with a 
volume 2 µl was combined with an 1.8 µl of reservoir solution containing 0.1 M Tris-HCl 
pH 9.0, 300 mM NaCl, 40% v/v PEG 4,000 and 0.2 µl of 10% w/v 1,2,3-heptanetriol. 
Small hexagonal crystals appeared within 3-5 days and grew to full size 50 µm x 70 µm x 
25µm within four weeks (Figure 4.3).  
 
Figure 4.3 Image of SMN-Δ7 protein crystals. 
   47 
Data collection 
The SMN-WT crystals were frozen in liquid nitrogen and sent to the Advanced 
Light Source (ALS) beamline 5.0.1 at the Lawrence Berkeley National Laboratory. The 
SMN-WT crystal data collection was performed by Meitian Wang at ALS and found to 
diffract to a resolution limit of 5.5 Å. The SMN-WT diffraction data was indexed, 
refined, and integrated using software package CrystalClear 1.3.5 (Rigaku-MSC) and 
scaled using SCALA (CCP4). The SMN-WT crystals belonged to the space group C21 
with cell dimensions a = 137.04 Å, b=169.82 Å, c=108.78 Å along with angles α=90°, 
β=128.54°, γ=90°. The SMN-WT data contained total and unique reflection of 24,090 
and 7,946, respectively. Data contained I/σ (I) and Rmerge value of 4.6 and 14.5 %, 
respectively, with 61.3% completeness. 
The SMN-Δ7 crystals were frozen in liquid nitrogen and sent to the Brookhaven 
National Laboratory (BNL). The SMN-Δ7 crystal data collection was performed at the 
BNL on the NSLS-X126 beamline using an ADSC detector at a wavelength of 1.081 Å 
by Chad Simmons. A full diffraction data set was measured to a resolution limit of 3.0 Å 
(Figure 4.4). The SMN-Δ7 diffraction data was indexed, refined, and integrated using 
MOSFLM (Leslie, 1999) and scaled using SCALA (CCP4 1994). The SMN-Δ7 crystal 
belonged to the space group C21 with unit cell dimensions a = 107.10 Å, b=62.29 Å 
c=57.07 Å along with an angles α=90°, β=95.07°, γ=90°. The SMN-Δ7 data contained 
total and unique reflection of 22,532 and 7,286, respectively. Diffraction data contained 
I/σ (I) and Rmerge value of 4.1 and 35.2 %, respectively, with 96.7% completeness. 
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Figure  4.4. Image of X-ray diffraction of SMN-Δ7. 
Data analysis 
The SMN-14 structure (Chapter 3) was used as a search model for the SMN-Δ7 
structure determination since the SMN 1-4 structure is 2/3 of the SMN-Δ7. The initial 
phases were determined using molecular replacement method using PHENIX (Adams et 
al., 2010). After processing, an electron density map was generated and the SMN-Δ7 
structure resulted one subunit in asymmetric unit. The SMN-Δ7 structure was manually 
built using COOT based upon the electron density map with alternative rounds of 
refinement using PHENIX (Adams et al., 2010). 
Due to the limitation of the SMN-WT resolution limit, 5.5 Å, SMN-Δ7 was built 
first. Then the complete SMN-Δ7 structure was used as a search model for the molecular 
replacement using Phaser (McCoy et al., 2007) for SMN-WT structure. The data 
processing shown that the SMN-WT obtained three subunits in asymmetric unit and 
electron density map generated for the model building. The SMN-WT structure was 
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manually built using COOT based upon the electron density map with alternative 
refinement using PHENIX (Adams et al., 2010). 
Refinement 
Procheck and Sfcheck programs were also used to verify the protein structures 
with the diffraction data and structural model (Laskowski et al., 1993 and Vaguine et al., 
1999). The complete model of SMN-Δ7 agree with the electron density map as shown by 
the Rwork and Rfree values of 38.90 % and 42.08 %, respectively. The Ramachandran plots 
of SMN-Δ7 model had 97.60 % and 16.10 % in the preferred region and allowed region, 
respectively, with no outlier.  The root mean squared deviations of bond distances and 
angles are 0.004 Å and 1.102°, respectively. 
The complete model of SMN-WT has Rwork and Rfree values of 30.68% and 
32.89%, respectively. Due to the limited resolution, only the backbone of SMN-WT has 
been reliably built in the electron density. 
 Pymol has been used for structural model viewing and the creation of most of the 
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Table 4.1. Summary of X-ray diffraction data and refinement of SMN-WT and SMN-Δ7 
 SMN-WT   SMN-Δ7 
Space group C21    C21 
Resolution limits (Å) 5.5     3.0 
Unit Cell (Å) a = 137.04, b=169.82,  a = 107.10, b=62.29, 
 c=108.78    c=57.07 
Angle (°) α=90, β=128.54, γ=90  α=90, β=95.07, γ=90 
Reflections: 
 Total 24,090   22,532 
Unique 7,946   7,286 
Multiplicity 3.0    3.1     (3.0) 
I/σ (I) 4.6    4.1     (2.1) 
RMerge (%) 14.5    35.2   (0.54) 
Completeness (%) 61.3    96.7   (98.30) 
Refinement 
Rwork (%)/Rfree (%) 30.68 /32.89   38.90/42.08 
Number in asymmetric unit 3    1 
RMSD Bond length (Å) NA    0.004 
RMSD Bond angle (°) NA    1.102 
Ramachandran plots 
 Preferred (%) NA    97.60 
 Allowed (%)     NA        2.30 
 Outlier (%)     NA      0.00 
R-factor =Σ| |Fobs| -|Fcal||/ Σ |Fobs|, Free R-factor was calculated with setting aside 5% of 
the reflection data. Rmerge = ΣhklΣj |Ij(hkl) – [I(hkl)] | ΣhklΣj[I(hkl)] where Ij(hkl)is the 
intensity reflection, and I(hkl)is the mean intensity of symmetry related h, k, l. 
Number in the parenthesis is the outer shell value. 
Three-dimensional structure of SMN-Δ7 
The three-dimensional structure of SMN-Δ7 forms a monomer with 282 amino 
acid residues and folded into β-strands and α-helices (Figure 4.5). All the β-strands form 
an antiparallel β-sheet and β-folded. The α-helices are found in both the C-terminal and 
N-terminal region. The N-terminal α-helices, α1 and α2, are located after three of 
antiparallel β-strands, β1-β3, and the other two α-helices, α3 and α4, are located at the end 
of the C-terminal region. The secondary structure and domain arrangements of the SMN-
Δ7 are summarized in Table 4.2. 
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Figure 4.5. Three-dimensional structure of SMN-Δ7 consists of 16 β-
strands and 4 α-helices. 
 
The three-dimensional structure of SMN-Δ7 consists of four domains (Figure 
4.6). Domain 1 consists of 5 antiparallel β-strands, β1-β5 (Figure 4.6a) and two α-helices, 
α1 and α2, whereas domain 2 (Tudor domain) consists of 5 antiparallel β-strands, β6-β10 
(Figure 4.5b). Domain 3 consists of 4 antiparallel β-strands, β11-β14 (Figure 4.6c). 
Domain 4 consists of two bent antiparallel β-strands, β15-β16 and one long, α3, and short 
α-helix, α4 (Figure 4.6d). Domain 2 and 3 are shown to have similar fold and it is shown 
as the mirror image of each other (Figure 4.5). Domain 1, 2, and 3 mostly form β-strands 
whereas domain 4 consists of two long β-strands, and two α-helices. 
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Figure 4.6. Domains of SMN-Δ7. a) Domain 1 shown in red. b) Domain 2 
shown in green. c) Domain 3 shown in blue and d) Domain 4 shown in 
yellow.  
Table 4.2 Summary of secondary structure and domain arrangement of SMN-Δ7 
Residues Secondary Structure Domain 
8-14 β1 1 
19-26 β2 1 
29-36 β3 1 
40-45 α1 1 
48-62 α2 1 
64-70 β4 1 
75-83 β5 1 
97-102 β6 2 (Tudor domain) 
106-117 β7 2 (Tudor domain) 
122-127 β8 2 (Tudor domain) 
131-137 β9 2 (Tudor domain) 
142-148 β10 2 (Tudor domain) 
153-158 β11 3 
164-174 β12 3 
178-184 β13 3 
190-194 β14 3 
230-237 β15 4 
240-250 β16 4 
255-260 α3 4 
263-278 α4 4 
 
 
Three-dimensional structure of SMN-WT 
The three-dimensional structure of SMN-WT consists of three identical proteins 
with each protein containing 294 amino acid residues. The three proteins A, B and C are 
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shown in green, blue and red respectively (Figure 4.7). Protein A and C forms as a mirror 
image to each other and protein B locates in the middle approximate 1/3 of protein A and 
C. The α-helices of the protein A and C are exposed to the surface region whereas the α-
helices of protein B are buried within the two proteins, A and C.  
The α-helices of the protein A and C are exposed to the surface region whereas 
the α-helices of protein B are buried within the two proteins, A and C. All the β-strands 
form an antiparallel β-sheet and β-folded and buried inside the structure whereas the α-
helices are exposed to the surface of the structure.  
 
Figure 4.7. The three-dimensional structure of SMN-WT. The SMN-WT 
shows three identical subunits A, B and C, which are shown in green, blue 
and red, respectively.  
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The α-helices are positioned at the N-terminal and C-terminal region of the 
structure (Figure 4.8). The N-terminal α-helices, α1 and α2, are located after three of 
antiparallel β-strands, β1, β2, and β3, and the other two α-helices, α3 and α4, and helix-turn-
helix are located at the end of the C-terminal region.  
 
Figure 4.8. The monomer of SMN-WT. 
Each protein consists of four domains containing β-strands and several α-helices. 
Domain 1, β1-β5 and α1-α2, forms four antiparallel β-strands and a short α-helix (Figure 
4.9a).. Domain 2 forms four antiparallel β-strands, β6-β9, and a short turn (Figure 4.9b). 
Domain 3 forms a short turn and four antiparallel β-strands, β10-β12 (Figure 4.9c) and 
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domain 4 forms short α-helix, α3, helix-turn-helix and long α-helix, α4 (Figure 4.9d). The 
secondary structure and domain arrangements of the SMN-WT are summarized in Table 
4.3. 
 
Figure 4.9.  Comparison of SMN-WT domains. a. Domain 1, b. domain 2, c. 
domain 3 and d. domain 4 are shown in orange, green, blue and red, respectively.  
 
Table 4.3 Summary of secondary structure and domain arrangement of SMN-WT 
Residues Secondary Structure Domain 
8-14 β1 1 
19-26 β 2 1 
29-36 β 3 1 
40-45 α 1 1 
48-62 α 2 1 
64-70 β 4 1 
75-83 β 5 1 
97-102 β 6 2 (Tudor domain) 
106-117 β 7 2 (Tudor domain) 
122-127 β 8 2 (Tudor domain) 
131-136 β 9 2 (Tudor domain) 
138-141 Short turn 2 (Tudor domain) 
145-147 Short turn 3 
153-158 β 10 3 
164-173 β 11 3 
178-184 β 12 3 
188-194 β 13 3 
233-240 α 3 4 
250-260 Helix-turn-helix 4 
263-278 α 4 4 
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Significant difference of SMN-WT and SMN-Δ7 is that the SMN-Δ7 form single 
subunit and SMN-WT forms a trimer in asymmetric unit. Besides, the SMN-Δ7 has the 
two β-stands, β15 and β16, the short loop at the C-terminus of SMN-Δ7 (Figure 4.10a). The 
three-dimensional structure of the SMN-WT protein has the same general fold as the 
SMN-Δ7, except the short turn in domain 2 and domain 3 shown in Figure 4.9b and 4.9c, 
respectively, helix-turn-helix and the long extended loop at the C-terminal region 
(residues 278-294) (Figure 4.10b). These differences may possibly cause the defect in 
oligomerization (Buhler et al., 1999; Burghes and Beattie, 2009; Martin et al., 2012) and 
disrupt the assembly of Sm proteins, which lead to reduce the snRNP assembly.  
 
Figure 4.10. Comparison of C-terminal region of SMN-Δ7and SMN-WT. a) 
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Chapter 5 
THE THREE-DIMENSIONAL STRUCTURE OF FMO PROTEIN FROM Pelodictyon 
phaeum 
Introduction 
The Fenna-Mathews-Olson protein belongs to a diverse family of pigment–
protein antenna complexes in some photosynthetic organisms that capture light and direct 
this energy to the integral membrane reaction center complexes where it is converted into 
chemical energy to generate energy rich compounds (Blankenship, 2002). In green sulfur 
bacteria, light is absorbed by chlorosomes, which are large complexes attached to the 
cytoplasmic side of the inner cell membrane (Oostergetel et al., 2007; Psencik et al., 
2004; Staehelin et al., 1980). The light energy is transferred from the chlorosome to a 
bacteriochlorophyll (BChl) a-containing FMO protein (Olson, 2004). The FMO protein is 
a water-soluble protein but is embedded in the cytoplasmic membrane and serves as an 
energy transfer funnel between the chlorosome and the integral membrane protein called 
the reaction center, which is the site of the conversion of the light energy into a charge-
separated state (Wen et al., 2009).  
Due to the key role that FMO plays in the transfer of energy from the chlorosome 
to the reaction center, the properties of FMO have been subjected to considerable study. 
The presence of several BChl cofactors has provided the opportunity to probe the 
electronic states of the FMO after light excitation using steady-state and transient optical 
spectroscopy (Milder et al., 2010). However, the BChl cofactors are highly interacting, 
which makes assignment of the spectral features to individual cofactors problematic, 
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especially since the energy transfer processes involve quantum effects (Adolphs and 
Renger, 2006; Engel et al., 2007; Gülen, 1996; Iseri and Gülen, 1999; Louwe et al., 1997;  
Lu and Pearlstein, 1993; Mohseni et al., 2008;  Müh et al., 2007; Vulto et al., 1998a, b, 
1999; Wendling et al., 2002). Time-resolved 2D optical spectroscopy has provided the 
experimental means to probe the couplings between the BChl cofactors although 
interpretation at a molecular level requires use of a exciton Hamiltonian (Brixner et al., 
2005; Panitchayangkoon et al., 2010; Read et al., 2007).  
The FMO complex from Prosthecochloris aestuarii (Ptc. aestuarii) 2K was the 
first protein containing BChl to be crystallized (Olson, 1978) and have its three-
dimensional structure determined using X-ray diffraction (Matthews et al., 1979; Tronrud 
et al., 1986). Subsequently, the structure of the FMO complex from Chlorobaculum 
tepidum (Cbl. tepidum), previously named Chlorobium tepidum, was determined 
(Camara-Artigas et al., 2003; Li et al., 1997). Both complexes are trimers with three 
identical subunits that are related by a threefold symmetry axis. Each protein subunit was 
found to embed seven BChl cofactors although more recent structures have identified an 
eighth BChl cofactor that is present with a range of occupancies (Ben-Shem et al., 2004; 
Tronrud et al., 2009). The structure of Cbl. tepidum is similar to that of Ptc. aestuarii 2K 
reflecting the significant sequence homology found for the FMO proteins (Tsukatani et 
al., 2010). To understand the relationship between the structure and energy transfer 
function, we have determined the three-dimensional structure of the FMO protein from a 
third organism, Pelodictyon phaeum (Pld. phaeum), which had been predicted to have 
significant structural differences compared to Cbl. tepidum and Ptc. aestuarii 2K based 
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upon a comparison of the spectroscopic properties (Hu, 2001). In this chapter, the three-
dimensional structure of the FMO from Pld. phaeum as determined using protein 
crystallography is described. The availability of this new structural model presents the 
opportunity to re-examine the structural aspects that give this complex the ability to 
perform energy transfer with unusual quantum contributions.  
My contribution to this chapter is solving the three-dimensional structure of the 
FMO protein from Pld phaeum in which crystallographic data were obtained from other 
authors in the published paper (Larson et al., 2011). The purified FMO protein was 
obtained from the laboratory of Robert Blankenship at Washington University at St. 
Louis, Missouri. 
Materials and methods 
Protein expression and purification 
The Pld. phaeum cells were grown anaerobically at room temperature with 
~100 µE light intensity for 3–5 days in two 15 l sealed carboys. The FMO protein was 
isolated essentially as previously described (Li et al., 1997). The FMO protein was 
extracted from the membrane by Na2CO3, and collected as a supernatant after 
ultracentrifugation. The crude FMO extract was dialyzed against Tris/HCl buffer (pH 
8.0) until the pH dropped to 8.0. The FMO protein was then purified by a combination of 
a Q Sepharose HP ion exchange column (GE Healthcare, USA) and an S-300 Sephacryl 
HR gel filtration column (GE Healthcare, USA) until the final OD267/OD371 < 0.56. The 
protein was stored in 20 mM Tris/HCl pH 8.0 and 50 mM trisodium citrate prior to 
crystallization.  
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Results 
Crystallization 
Crystals of the FMO protein were obtained using the hanging drop method. The 
protein sample concentration was poised at an absorbance of 9.0 at 810 nm, 
corresponding to a concentration of approximately 6 mg/ml, in a 50 mM disodium citrate 
buffer. The original conditions tested for crystallization were based upon the conditions 
used to crystallize the FMO from Cbl. tepidum (Li et al., 1997), which had the protein 
solution mixed with an equal volume of the reservoir containing 6% polyethylene glycol 
(PEG) 4,000, 20% 2-propanol, and 0.1 M sodium citrate (pH 5.6). The optimal conditions 
had a reservoir solution containing 0.1 mM 4-(2-hydroxyethyl)-1-
pipersazineethanesulfonic acid (pH 7.5), 16% PEG 2,000 monomethyl ether with a 
volume of 0.4 ml. The protein drop had a volume of 2 µl and was poised at 3 mg/ml with 
0.05 mM 4-(2-hydroxyethyl)-1-pipersazineethanesulfonic acid (pH 7.5), 25 mM citrate, 
and 4% PEG 2,000 monomethyl ether. The trays were kept at room temperature in the 
dark with blue-green crystals appearing in 2–3 days and reaching full size in 2 weeks. 
Prior to the diffraction measurements, the crystals were placed into a cryoprotectant 
consisting of 60% PEG 400, 10% PEG 2,000 monomethyl ether, and 10 mM citrate.  
Data collection and refinement 
Green hexagonal crystals of FMO from Pld. phaeum grew with a typical length of 
0.1 mm and 0.05 mm width. The crystals belonged to the hexagonal space group P63 with 
unit cell dimensions of a = b = 84.0 Å and c = 115.8 Å along with angles α = β = 90° and 
γ = 120° with one protein subunit per asymmetric unit (Table 5.1). Diffraction data were 
measured from a single crystal at the Brookhaven National Laboratory on the NSLS-
   63 
X126 beamline using an ADSC detector at a wavelength of 1.081 Å. A full diffraction 
data set was measured to a resolution limit of 1.99 Ǻ, integrated using MOSFLM (Leslie, 
1999), and scaled with SCALA (CCP4 1994). The initial phases were determined using 
the molecular replacement method using PHENIX (Adams et al., 2002) with the 3EOJ 
model of the FMO from Ptc. aestuarii 2 K (Tronrud et al., 2009). A unique orientation 
and position were obtained. Manual model building for all structures was performed in 
Coot (Emsley and Cowtan, 2004) with iterative rounds of refinement being performed 
using PHENIX. Procheck (Laskowski et al., 1993) and Sfcheck (Vaguine et al., 1999) 
were applied to verify the completed structures. The completed model has Rwork and Rfree 
values of 16.6% and 19.9%, respectively. All of the amino acids are evident within the 
electron density except for the first four amino acids at the N-terminus and two residues 
209 and 210 that are part of a loop between two β-strands. Two prolines, 41 and 324, are 
in a cis conformation. The Ramachandran plot showed 93.3% in the preferred region and 
6.7% in the allowed regions without outliers. The average temperature factors for the 
protein and water molecules are 21.0 and 37.8 Å2, respectively, yielding an overall value 
of 22.7 Å2. The root mean square deviations of bond distances and angles are 0.007 Å 
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Table 5.1.  Crystallographic data summary of FMO from Pelodictyon phaeuma  
Space group P63 
Resolution limits (Å) 48.0 – 1.99 (2.05 – 1.99) 
Unit Cell (Å)    a = b = 84.0, c = 115.8  
Angle (°) α = β = 90, γ = 120 
Data Collection      
Beamline NSLS-X126 
Wavelength (Å) 1.0809  
Reflections: 
Total  230,676 
Unique    29,966 
Multiplicity 7.7 
I/σ (I) 2.0 (1.2) 
RMerge (%)b 0.186 (0.58) 
Completeness (%) 94.5 % 
Refinement 
Rwork (%)/Rfree (%)c 16.6/19.9 
Number in asymmetric unit 1 
Average B-factor (Å2) 22.7 
Residues modeled (#) 4 - 208, 211 - 362 
Number of ligand/ion atoms 0 
Number of water molecules 363 
RMSD Bond length (Å)  0.007 
RMSD Bond angle (°)   3.027 
Ramachandran plots 
 Preferred (%)   93.3 
 Allowed (%)   6.8 
 Outlier (%)   0 
aNumbers in the parentheses are for the outer shell 
bRmerge = ΣhklΣj |Ij(hkl) – [I(hkl)] | ΣhklΣj[I(hkl)] where Ij(hkl)is the intensity reflection, 
and I(hkl) is the mean intensity of symmetry related h, k, l 
cRwork =Σ| |Fobs| -|Fcal||/ Σ |Fobs|, Rfree was calculated by setting aside 5% of the reflection 
data 
Three-dimensional structure of the FMO protein from Pld. phaeum  
The FMO protein from Pld. phaeum consists of three identical subunits with each 
subunit consisting of 362 amino acids that form a number of long and short β-strands and 
several α-helices (Figure 5.1). The two large β-sheets form a ‘taco shell’ surrounding the 
eight BChl cofactors. β-strands 1 and 2 run anti-parallel to each other and start the largest 
β-sheet. Adjacent to strand 2 are anti-parallel β-strands 11–12 and 3–4 and adjacent to 
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strand 1 are strands 13–17. The second β-sheet wraps around behind the first sheet and is 
formed by β-strands 5–10. The open section of the two large β-sheets is closed by the 
presence of 6 α-helices and connecting loops. Helix 1 is situated behind the largest β-
sheet and is exposed at the surface of the subunit.  
The three identical subunits are arranged as a trimer with each subunit related by a 
crystallographic threefold axis of symmetry. The trimer is approximately cylindrical in 
shape with an 8 nm diameter and a 5 nm height. The trimer is positioned in the cell 
membrane with the threefold symmetry axis approximately perpendicular to the 
membrane surface, with one face oriented toward the chlorosome and the other face 
toward the membrane (Melkozernov et al., 1998; Wen et al., 2009). This orientation 
places the more hydrophobic surface of the trimer interacting with the baseplate of the 
chlorosome and the more hydrophilic surface partially embedded into the phospholipid 
head groups of the cell membrane and adjacent to the reaction center. The resulting 
alignment of α-helices 5 and 6 toward the membrane has been proposed to facilitate 
energy transfer to the reaction center (Müh et al., 2007).  
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Figure 5.1. The three-dimensional structure of FMO from Pld. phaeum. In 
the cell, the protein is a trimer with the three identical subunits related by a 
crystallographic threefold symmetry axis approximately vertical to the 
plane. The protein subunits (sand) surround eight BChls cofactors (atom 
type). The α-helices close off the fold and provide important protein–
protein contacts to form the trimer. BChl 8 is located at the interface 
between two subunits. Coordinates shown are 3OEG for Pld. phaeum.  
 
The three interacting subunits have a number of contacts between each subunit 
that hold the trimer together, primarily involving β-strand 8 and α-helices 1, 2 and 3. A 
large number of protein–protein interactions are found at the interfaces between the 
subunits that contribute to the stability of the trimer (Figure 5.2). The predominant amino 
acids are polar and charged residues Asp, Asn, Glu, Arg, Lys, and Ser, many of which 
form salt bridge contacts between the subunits. Most of these interactions are well 
conserved, for example in one region of the interface, Arg127 of α-helix 1 forms a bridge 
with Asp*103 and Asp*153, where * represents the neighboring monomer, that is in α-
helix 2 of the neighboring monomer. Asn 128 also forms a salt bridge contact with Asp 
*103. In other regions, Arg 138 of β-strand 8 forms a bridge with Glu*178 of α-helix 3. 
Tyr119-Glu*178 is one such polar interaction. Also, Arg195 is found in a loop region and 
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forms a bridge with Glu*178 of α-helix 3 and Asp*174 also from α-helix 3. While these 
interactions are generally conserved, there is a unique salt bridge that occurs in Pld. 
phaeum between Asp123 and Glu*156.  
Each subunit surrounds seven BChl molecules, identified as BChl 1 through 7, 
with an eighth BChl, identified as BChl 8, on the interface with the neighboring protein 
subunit of the trimer (Figure 5.3). The BChl molecules are arranged in an asymmetric 
fashion. Considering only BChl 1–7, the closest distance between any two BChls within 
any subunit, as measured by the Mg to Mg distance, is 11 Å and the farthest distance is 
30 Å. None of the BChls from one subunit are near any from the neighboring subunit, 
with the closest distance being 25 Å. In contrast, BChl 8 is far from the other seven 
BChls within each subunit, with distances ranging between 20 and 40 Å, with BChl 6 
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 Figure 5.2. The interface between subunits of the trimer of FMO from 
Pld. phaeum. The interface between subunits is primarily stabilized by salt 
bridges such as those involving Asp103, Arg127, Asn128, and Asp153 for 
Pld. phaeum (carbons color coded sand or cyan depending upon subunit, 
oxygen red, nitrogen blue). Equivalent interactions are found involving 
Asp107, Asp127, Asn128, Arg131, and Asp157 in Cbl. tepidum and 
Asp107, Asp127, Arg131, Asn132, and Arg157 in Ptc. aestuarii 2K. Not 
all interactions are conserved, for example, the salt bridge between 
Asp123 and Glu156 is found only in Pld. phaeum. Coordinates shown are 
3OEG for Pld. phaeum. 
 
BChls 1–7 are all five-coordinated, to either a histidine, a backbone carbonyl, or a 
bound water molecule. His106 located in β-strand 7 coordinates BChl 1. BChl 2 is 
coordinated by a water molecule in close proximity to the side chain of Asn75. His294 
and His293 located in α-helix 7 coordinate BChl 3 and 7, respectively. The long loop 
connecting β-strands 12 and 13 contains His286 that serves as the axial ligand for BChl 4 
and BChl 6 is coordinated to His141 of β-strand 8. The backbone carbonyl of Leu238 of 
α-helix 5 ligates BChl 5. For the FMO from Pld. phaeum, BChl 8 is five-coordinated to 
the side chain of Ser164 but, unlike the other seven BChls, BChl 8 has many interactions 
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with amino acid residues from both subunits with notable differences found among the 
FMO structures as discussed below.   
 
Figure 5.3. The three-dimensional structure of the BChl cofactors of each 
subunit of FMO from Pld. phaeum. The BChls (atom type) are arranged in 
an asymmetric fashion and shown without the phytyl chains for clarity. 
Each BChl is numbered as described in the text. Coordinates shown are 
3OEG for Pld. phaeum (this work). Small sphere represent the Mg. 
 
Discussion  
The function of FMO is to transfer light energy from the chlorosomes to the 
reaction center where energy conversion occurs. The structure of FMO from Pld. phaeum 
has been solved at a resolution limit of 2.0 Å. The FMO protein is a trimer with each 
subunit forming a ‘taco shell’ arrangement of two β-sheets arranged with α helices filling 
the open end of the shell. There are numerous interactions between neighboring subunits 
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that stabilize the trimer, which is the biologically relevant structure. The two β-sheets 
surround a total of eight BChl molecules that are arranged with various separation 
distances without any symmetrical pattern. Seven of the BChls are buried within the 
protein and five-coordinated. The eighth BChl lies on the edge of the subunit at the 
interface formed with the neighboring subunit of the trimer.  
The backbone structure of the FMO from Pld. phaeum closely resembles those of 
the previously solved structures of the FMO protein from Ptc. aestuarii 2 K and Cbl. 
tepidum (Ben-Shem et al., 2004; Camara-Artigas et al., 2003; Li et al., 1997; Matthews et 
al., 1979; Tronrud et al., 1986; Tronrud et al., 2009). The structures from the three 
species can be closely overlaid showing all secondary structural features conserved, with 
an average rms deviation of 0.5 Å, with only minor differences for the connecting loops. 
This close match of the backbone reflects a strong sequence homology observed among 
the FMO proteins. An alignment of 17 FMO protein sequences, including Pld. phaeum, 
Ptc. aestuarii 2 K and Cbl. tepidum (Tsukatani et al., 2010), shows that most amino acid 
residues are conserved, with the notable exception of an aerobic phototrophic bacterium, 
Candidatus Chloracidobacterium thermophilum although in all species the critical amino 
acid residues forming the binding sites for the BChls are identical. Among the FMO from 
green sulfur bacteria, the sequences from Pld. phaeum and Ptc. aestuarii 2K are very 
closely conserved with both showing differences compared to Cbl. tepidum.  
In the alignment of the FMO from green sulfur bacteria, the longest continuous 
conserved length of amino acids is 14 residues with other stretches of 10, 8 and 7 
residues also occurring. There are multiple regions of 2–6 amino acids that are fully 
conserved throughout the sequences. Many of these conserved sections are clustered 
   71 
close to the coordinating residues for BChls 3 and 6 (Figure 5.4). BChl 6 has two short 
stretches of conserved residues (numbering for Pld. phaeum) that consist of residues 
110–116 and 136–143. BChl 3 has three different stretches of conserved residues that are 
in close proximity to it. The longest stretch has 14 residues numbering 254–267. The two 
smaller stretches include residues 290–299 and 346–352. It is interesting but not 
surprising that these two BChls have the longest conserved sections of amino acids. BChl 
3 is believed to be the lowest energy pigment that transfers energy from FMO to the 
reaction center and BCh 6 is believed to be one of the high-energy pigments as deduced 
from spectral fitting studies and structure-based calculations (Adolphs and Renger, 2006; 
Louwe et al., 1997; Müh et al., 2007; Vulto et al., 1998a, b; Wendling et al., 2002;). 
Thus, the strong conservation of amino acid residues surrounding BChl 3 and 6 reflects 
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Figure 5.4. Strongly conserved regions for FMO proteins from different species. 
Shown is the structure of the FMO from Pld. phaeum with the regions of 
conserved amino acids for FMO proteins from green sulfur bacteria highlighted in 
green. These conserved regions are clustered around BChl 3 (red), which is 
thought to be the lowest energy pigment that transfers energy to the reaction 
center, and BChl 6 (blue), and believed to be one of the highest energy pigments 
that is in close proximity to the chlorosome. Coordinates shown are 3OEG for 
Pld. phaeum (this work). 
This conservation of amino acid residues is also seen in the protein–protein 
interactions that are found in the interface between neighboring subunits of the trimer. 
Comparing the FMO proteins from Pld. phaeum, Ptc. aestuarii 2K, and Cbl. tepidum, the 
types of interactions are the same in all three structures with few notable differences (in 
comparing equivalent residues, the residue numbers for Pld. phaeum are shifted by four 
residues compared to Ptc. aestuarii 2K and Cbl. tepidum). For example, in one region the 
same salt bridges are present in all three structures involving amino acids from two 
different subunits, Asp103, Asp107, Asp127, Arg131, and Asp157 (Figure 5.2). The 
conservation of these interactions presumably is due to the trimeric nature of FMO in all 
species. 
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Comparison of protein–BChl interactions in the three FMO structures 
The availability of the high-resolution FMO structures from Pld. phaeum (this 
work), Cbl. tepidum and Ptc. aestuarii 2K (Tronrud et al., 2009) provides the opportunity 
to investigate the conservation of structural features of the BChl environments. BChl 1 
has its Mg coordinated with the same histidine axial ligand, namely, His106 in Pld. 
phaeum and His110 in Cbl. tepidum and Ptc. aestuarii 2K, but four differences are 
evident in the interactions with amino acid residues lying within 10 Å of the metal center 
(Figure 5.5). Within van der Waals distance of the macrocycle is Val99 in Pld. phaeum 
and Cbl. tepidum (Val 103) but Ptc. aestuarii 2 K has Leu103 in that equivalent location. 
Both Pld. phaeum and Ptc. aestuarii 2 K have a nearby Phe, namely, Phe161 and Phe165, 
respectively, but the interaction with an aromatic residue is lost with the presence of 
Thr165 in Cbl. tepidum. Also a serine is present for both Pld. phaeum and Cbl. tepidum at 
amino acid residues 217 and 220, respectively, compared to Thr221 for Ptc. aestuarii 
2 K. At 10 Å, a difference is also found with Pld. phaeum having Lys 107 but Ptc. 
aestuarii 2K has Ser111 and Cbl. tepidum has Thr111.  
A comparison of BChl 2 from the three species shows that there are a number of 
differences within a 10 Å environment (not shown). This BChl is located at a protein–
protein interface of the trimer and interacts with several residues from the adjacent 
subunit that are highly conserved. Unlike the other BChls, a bound water molecule rather 
than the protein coordinates the central Mg. In all structures, the bound water ligand is 
hydrogen-bonded to Asn, namely, Asn75 in Pld. phaeum and Cbl. tepidum and Asn79 in 
Ptc. Aestuarii 2K. However, the number of water molecules hydrogen-bonded to the 
water ligand is two in the FMO structure from Pld. phaeum, three in Ptc. aestuarii 2K 
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with two and three reported for Cbl. tepidum (Ben-Shem et al., 2004; Tronrud et al., 
2009). The impact of this variation of hydrogen bonds to the water ligand on the 
electronic structure of BChl 2 is not known.  
Different amino acids are adjacent to ring B of BChl 2 in each structure, Pld. 
phaeum (Leu37), Cbl. tepidum (Ser 41) and Ptc. aestuarii 2K (Ile41). Next to this amino 
acid residue is an Ala in Pld. phaeum and Cbl. tepidum, positions 42 and 46, respectively, 
but Ptc. aestuarii 2K has Thr46. Near ring A, Pld. phaeum and Ptc. aestuarii 2K have 
Ile66 and Ile70, respectively, but Cbl. tepidum has Phe70 in that location. Close to ring C 
is a Val in both Pld. phaeum and Cbl. tepidum, Val99 and Val103, respectively, while 
Leu103 is found in Ptc. aestuarii 2K. A difference further apart from the BChl is Thr73 
and Thr77 in Pld. phaeum and Cbl. tepidum, respectively, but Val77 in Ptc. aestuarii 2K.  
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Figure 5.5. Comparison of the structure of BChl 1 and nearby amino acid 
residues. All three structures have a His as an axial ligand for the Mg of 
the BChl, namely, 106 in Pld. phaeum and 110 in Ptc. aestuarii 2K and 
Cbl. tepidum (color coded by atom type with green and sand for carbon in 
BChl 1 and the protein, respectively). It shows that Pld. phaeum and Ptc. 
aestuarii 2K have Phe161 and Phe165, respectively, but Cbl. tepidum has 
Thr165 instead in that location. Two conservative differences are Val99 
and Ser217 in Pld. phaeum and Cbl. tepidum (Val103 and Ser220) but Ptc. 
aestuarii 2K has Leu103 and Thr221. In addition, the ionizable amino acid 
residue Lys107 is not present in Ptc. aestuarii 2 K or Cbl. tepidum, which 
have Ser111 and Thr111, respectively. Coordinates shown are 3OEG for 
Pld. phaeum (this work), 3EOJ for Ptc. aestuarii 2K (Tronrud et al., 
2009), and 3ENI for Cbl. tepidum (Tronrud et al., 2009).  
 
The region surrounding BChl 3 is highly conserved across all three species of 
bacteria for over 20 amino acids within a 10 Å distance from the Mg, including the 
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histidine coordinating the central Mg, namely, His294, 298, and 297 in Pld. phaeum, Ptc. 
aestuarii 2K, and Cbl. tepidum, respectively (not shown). One minor difference is that 
both Pld. phaeum and Ptc. aestuarii 2K have an Ala at residues 35 and 39, respectively, 
but Cbl. tepidum has Pro39. Also, Cbl. tepidum has a polar residue, Ser 41 rather than an 
aliphatic residue, namely, Leu37 and Ile 41, as found in Pld. phaeum and Ptc. aestuarii 
2K, respectively. This conservation of the binding site (Figure 5.4) is consistent with the 
hypothesis that the protein interactions need to be maintained in order for BChl 3 to serve 
its role of being the site where the exciton energy collects within the FMO protein before 
the energy is transferred to the reaction center (Louwe et al., 1997; Vulto et al., 1998a; 
Wendling et al., 2002). The environment around BChl 4 is also highly conserved with 
roughly 24 amino acids in close proximity, including the coordinating histidine residue, 
namely, His286, 290, and 289 in Pld. phaeum, Ptc. aestuarii 2K, and Cbl. tepidum, 
respectively (not shown). Three differences are observed at a distance of about 10 Å from 
the central Mg atom. Both Pld. phaeum and Ptc. aestuarii 2K have Leu269 and Leu273, 
respectively, while the corresponding residue is Phe272 in Cbl. tepidum. A second 
difference is that Pld. phaeum has Ile25 where Cbl. tepidum and Ptc. aestuarii 2K both 
have Val29 in that position. The third difference has Cbl. tepidum differing again from 
Pld. phaeum and Ptc. aestuarii 2K, Ala34 in Cbl. tepidum and Gly27 and Gly31 in Pld. 
phaeum and P. aestuarii 2K, respectively.  
There are a number of differences involving the interactions of BChl 5 with the 
surrounding protein although the coordination of the central Mg to the backbone oxygen 
of Leu238 in Pld. phaeum, or equivalently Leu242 and Leu241 in Ptc. aestuarii 2K and 
Cbl. tepidum, respectively, is present in all structures (Figure 5.6). Of the 27 amino acid 
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residues that lie at the 10 Å distance from the central Mg of the BChl, only six are closer 
than 8 Å and two of those six are not conserved. Near ring B, both Pld. phaeum and Ptc. 
aestuarii 2K have an aromatic residue, namely, Phe62 and Phe66, respectively, but Cbl. 
tepidum has Ile66. Near ring D is the difference that Cbl. tepidum has Phe272 and Pld. 
phaeum and Ptc. aestuarii 2K have the aliphatic residues Leu269 and Leu273, 
respectively. In addition, there are several smaller changes. The first minor difference is 
that Pld. phaeum and Ptc. aestuarii 2K have Ile48 and Ile52, respectively, while Cbl. 
tepidum has Leu52. The second is that Pld. phaeum and Ptc. aestuarii 2K are alike with 
Ala50 and Ala54 but Cbl. tepidum has Val54. The third is that Pld. phaeum and Ptc. 
aestuarii 2K are identical with Val241 and Val245 and Cbl. tepidum has Ser244. The 
final minor difference is that Pld. phaeum and Ptc. aestuarii 2 K both have an Ile at 250 
and 254, respectively, while Cbl. tepidum differs with Val253 in that position.  
The protein environments of BChls 6 and 7 are highly homologous with most 
amino acid residues being identical, including the coordinating histidines, namely, 
residues 141 and 293 in Pld. phaeum, 145 and 297 in Ptc. aestuarii 2K, and 145 and 296 
in Cbl. tepidum (not shown). One exception for the region of BChl 6 is near ring A where 
Phe 62 and Phe 66 are present in Pld. phaeum and Ptc. aestuarii 2K, respectively, but 
Cbl. tepidum has Ile 66. For BChl 7, Ile is found near ring A in Pld. phaeum and Cbl. 
tepidum, namely, positions 189 and 192, respectively, while Ile 193 is present in Ptc. 
aestuarii 2K.  
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Figure 5.6. Comparison of the structure of BChl 5 and nearby amino acid 
residues. All three structures have a backbone carbonyl as an axial ligand 
for the Mg of the BChl, namely, 238, 242, and 241 in Pld. phaeum, Ptc. 
aestuarii, and Cbl. tepidum, respectively (color coded by atom type with 
green and sand for carbon in BChl 5 and the protein, respectively). The 
binding site for BChl 5 shows a number of differences among the three 
species. Pld. phaeum and Ptc. aestuarii 2K have a phenylalanine residue, 
Phe62 and Phe66, respectively, but Cbl. tepidum differs with Ile66. A 
second difference is that Pld. phaeum and Ptc. aestuarii 2K have Leu269 
and Leu 273, respectively, where Cbl. tepidum has Phe 272. Another 
difference is that Pld. phaeum and Ptc. aestuarii 2K have a valine at 
residues 241 and 245, respectively, but Cbl. tepidum contains Ser 244. 
Other minor differences include Pld. phaeum having two isoleucine 
residues, Ile48 and Ile250, that are also found in Ptc. aestuarii 2K, 
namely, Ile52 and Ile254, with Cbl. tepidum differing with Leu52 and 
Val253 at the equivalent locations. Coordinates shown are 3OEG for Pld. 
phaeum (this work), 3EOJ for Ptc. aestuarii 2K (Tronrud et al., 2009), and 
3ENI for Cbl. tepidum (Tronrud et al., 2009). 
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Comparison of position and orientation of BChl 8 in the three FMO structures 
The three-dimensional structural models of the FMO proteins from Cbl. tepidum 
and Ptc. aestuarii 2K originally had seven BChls whose positions were well identified in 
the electron density calculated at resolution limits of 1.9–2.2 Å (Camara-Artigas et al., 
2003; Li et al., 1997; Matthews et al., 1979; Tronrud et al., 1986). In an effort to 
crystallize the FMO–reaction center complex, new conditions were identified that yielded 
the structure of the FMO protein at a resolution limit of 2.4 Å (Ben-Shem et al., 2004). 
Despite the higher resolution limit, a new feature in the electron density maps was the 
clear presence of an eighth BChl at the interface region between subunits in the trimer. 
This BChl has an axial coordinate to the backbone carbonyl of Tyr124. By comparison, 
the electron density for the eighth BChl was very incomplete in the other data sets with 
the electron density in that region being unidentifiable (Tronrud et al., 2009). 
Presumably, BChl 8 is labile and in the course of purifying the FMO protein this cofactor 
can be lost. For the FMO protein from Ptc. aestuarii 2K, the electron density in that 
region was modeled as arising from the protein in two different conformations, one with 
the site occupied and the other with the cofactor missing (Tronrud et al., 2009). In those 
models the unoccupied conformation has some large changes, for example Tyr124 and 
seven bound water molecules occupy the position normally occupied by BChl 8. From 
this density, it is difficult to assign the precise location and orientation of the BChl, and 
the model has the cofactor located based upon the model of the FMO from Cbl. tepidum. 
With this positioning, BChl 8 has two axial ligands provided by the side chain of Ser168 
in addition to the backbone carbonyl of Asp123.  
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The region for BChl 8 has weak electron density and has been re-interpreted by 
Tronrud and Allen (Tronrud and Allen, 2012). This new model of FMO from Pld. 
phaeum was refined using Buster program (Brigcogne et al., 2009) and refit with Coot, 
which improved Rwork and Rfree values to 16.21% and 19.02%, respectively (Tronrud and 
Allen, 2012). The new model is identical to the previous, except the region of BChl 8 is 
fitted by a fragment of polyethylene glycol (PEG) and two water molecules (Figure 5.7) 
(Tronrud and Allen, 2012). There remains an unassigned region of electron density, 
which could be the BChl 8 molecule with low occupancy.  
 
Figure 5.7. Superposition of the old model and the new model of BChl 8 with the 
omit electron density map. a. The Bchl 8 and two water molecules from the 
published model (3OEG). b. The new model (3VDI) with its PEG fragment and 
two water molecules occupying the strongest density (Tronrud and Allen, 2012). 
Implications for optical spectroscopy and energy transfer 
The FMO proteins have a characteristic optical absorption spectrum at room 
temperature, with a QY peak at 808–810 nm, a QX peak at 600–602 nm, and a Soret band 
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at 370–371 nm. Correspondingly, the fluorescence emission has a peak at 814–816 nm. 
However, both the absorption at 77K and room temperature circular dichroism spectra 
show distinct components, with the FMO protein from Pld. phaeum having a number of 
distinct spectral features compared to the FMO proteins from Ptc. aestuarii 2K, Cbl. 
tepidum, Chlorobium limicola, Chlorobium vibrioforme, and Chlorobium 
phaeovibrioides (Hu, 2001; Tronrud et al., 2009). For Pld. phaeum, three peaks are 
evident in the spectrum in the QY region centered at 805, 814, and 824 nm with a 
shoulder at 795 nm (Figure 5.8a). The band at 805 nm has the highest amplitude among 
these five species. For the other four species, the relative intensities differ and the peaks 
are slightly shifted relative to the FMO from Pld. phaeum. For example, the spectrum of 
Cbl. tepidum has peaks at 805 nm, 814 nm, and 824 nm but the ratio of the amplitudes of 
the 815 peak compared to the 805 nm peak is less than one in contrast to a ratio greater 
than one for Pld. phaeum.  
The CD spectrum of Pld. phaeum also shows differences when compared to the 
spectra of FMO from the other species (Figure 5.8b) (Hu, 2001). At room temperature, 
FMO from Pld. phaeum shows a maximum at 797 nm and two minima at 780 and 
821 nm. Small differences are evident in the position of these features in the other 
spectra. For example, these three features are also found in Cbl. tepidum but the 
maximum occurs at 796 nm and the minima occur at 780 and 824 nm. The largest 
discernable difference between the two species is the absence of a shoulder at 808 nm in 
the spectrum of Pld. phaeum. These spectral differences are more pronounced when the 
temperature is lowered. The spectrum from Pld. phaeum has one positive peak at 802 nm 
   82 
and two minima at 790 and 821 nm. There are also two shoulders that are found at 810 
and 817 nm. The low temperature CD spectrum from Cbl. tepidum has two positive peaks 
at 800 and 813 nm, and two minima at 807 and 825 nm. There are no shoulders seen in 
the low temperature CD spectrum of Cbl. tepidum.  
 
Figure 5.8. Absorption and CD spectra of five FMO proteins. a). 
Absorption spectra at of five FMO proteins at 77K. b). CD spectra of five 
FMO proteins at room temperature. A) Chlorobium limicola, B) 
Chlorobium tepidum, C) Pelodictyon phaeum, D) Chorobium 
phaeobacteriods, E) Chorobium vibroforme (Hu, 2001).  
Detailed theoretical analyses have been performed to better understand the 
energetics and energy transfer properties of the FMO proteins (Milder et al., 2010). Key 
to these functional properties is the extensive electronic couplings among the BChl 
molecules. The spectral features of the low temperature absorption and circular dichroism 
spectra have been modeled in terms of these excitonic interactions among the BChl 
pigments. Thus, the differences in the spectral features of the FMO protein from Pld. 
phaeum compared to the other species reflect differences in the couplings that could arise 
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due to a number of structural factors. For BChls 1–7, the position, orientation, and protein 
interactions of the three structures are largely similar; in particular the coordination is 
identical in all three cases. Some differences are apparent in the protein environment, 
although the impact of these differences on the spectral properties is not established. The 
planarity of the macrocycles can play a critical role in the electronic structure as 
discussed elsewhere (Li et al., 1997). In addition, long-range Coulomb interactions may 
be important in tuning the site energies of the BChls resulting in energetic differences 
despite similar local environments. Thus, the spectral differences of Pld. phaeum 
compared to FMO from the other species should reflect the effect of both local and long-
range structural differences.  
The theoretical studies of the spectra and energy transfer properties of the FMO 
have focused on individual subunits containing seven BChl molecules and consequently 
seven exciton levels (Milder et al., 2010) although a hole-burning study was interpreted 
in terms of eight exciton components (Johnson and Small, 1991). While BChls 1–7 have 
close interactions within each subunit of the trimer, the closest distance between any of 
these BChl from two different subunits is over 23 Å. The presence of BChl 8 alters the 
spectral interpretation, as this cofactor bridges the neighboring subunits of the trimer and 
is close to BChl 1 of the neighboring subunit (Figure 5.9). While many different factors 
influence the coupling (Renger, 2010), since one of the primary factors is the separation 
distance, BChl 8 should be coupled with BChl 1 and influence the spectral features 
associated with BChl 1 and 2. In particular, theoretical calculations suggest that BChl 1 
has a strong influence on excitons corresponding to the optical transitions at 790 and 
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809 nm and so the addition of couplings involving BChl 8 would impact this optical 
region as found in the circular dichroism spectra.  
 
 
Figure 5.9. Cofactor arrangement in FMO from Pld. phaeum with exciton 
couplings. Shown are BChls 1–8 (colored by atom type with green carbon) 
as well as a BChl 8 from a neighboring subunit (BChl *8) of the trimer 
(colored by atom type with cyan carbon). The calculated couplings 
between BChls are illustrated by ellipses (red and blue) with the direction 
of energy flow shown by arrows (red and blue). The distance between 
BChl *8 and BChl 1 is comparable to those found between other coupled 
BChls leading to the prediction of an additional coupling as illustrated by 
an ellipse between BChl *8 and BChl 1 (orange) that has not been 
included in any of the exciton models. Coordinates shown are from 
PDB:3OEG for Pld. phaeum (this study). Figured adapted from Brixner et 
al., 2005. 
In summary, the three-dimensional structure of FMO from Pld. phaeum has been 
determined to a resolution limit of 2.0 Å. A strong conservation is evident for many 
structural features, including the arrangement of BChls 1–7 and the protein region 
surrounding BChl 3. However, the position, orientation, and coordination of BChl 8 
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could only be placed based upon the other FMO structure due to weak electron density. A 
comparison of the structural aspects should account for the observed spectroscopic 
similarities and differences, especially when the contribution of BChl 8 is included. 
Together these FMO structures provide a structural platform for understanding the 
quantum effects and other features involving the energy transfer function of this BChl–
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Chapter 6 
THREE-DIMENSIONAL STRUCTURE OF SYNTHETIC ATP BINDING PROTEIN 
(DX) 
Introduction 
Besides solving the three-dimensional structures of SMN proteins and FMO 
protein, the three-dimensional structure of DX protein was also determined. The protein 
DX is a synthetic ATP binding protein resulting from in vitro selection process to mimic 
the enzymatic activity to the natural enzyme. The protein was synthesized and its 
biochemical properties were characterized and compared to the known biological ATP 
binding protein. Synthetic proteins have been designed with random selection from a 
DNA library. A protein pool containing a 6x1012 purified non-redundant random proteins 
each containing 80 amino acid residues was generated from a mRNA library of 4x1014 
independent random sequences with specific constructs to avoid stop codons and frame 
shift mutation (Keefe and Szostack, 2001). After 18 round of random selections the first 
de novo protein, namely 18-19, with a high affinity ATP binding (kd =100 nM) was 
selected from this pool (Keefe and Szostack, 2001).  
The three-dimensional structure of protein 18-19 has been solved using X-ray 
crystallography (Surdo et al., 2004 and Smith et al., 2007). The structure revealed a novel 
α/β fold with ATP and a Zn metal cofactor to stabilize the protein fold that has not been 
seen in nature. To improve the stability of 18-19 protein, amino acid residue number 32 
was mutated from glutamine to aspartic acid (N32D) and amino acid residue number 45 
was mutated from aspartic acid to valine (D45V) yielding the double mutants, DX, 
protein (Figure 6.1). Surprisingly, the three-dimensional structure of the DX protein 
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shares the same folding features as protein 18-19 with ATP and Zn cofactor (Smith et al., 
2007) (Figure 6.1). 
To identify the conformational changes in the DX protein in the absence of ATP, 
it was not introduced during the purification process. The DX protein was crystallized 
and structure was solve using X-ray diffraction. The crystallization and three-dimensional 
structure of the DX protein are described in this chapter. 
 
Figure 6.1. Three-dimensional structure of 18-19 and DX proteins 
(Simmons et al., 2010). 
 
 In this chapter, a purified DX protein was obtained from the laboratory Dr. John 
Chaput at the Biodesign Institute at Arizona State University and my contribution is the 
crystallization, data collection, data analysis, and solving the three-dimensional structure 
of DX. 
Results and discussion 
Protein crystallization 
  The DX protein was crystallized using the hanging drop vapor diffusion method 
at room temperature. The protein concentration was approximately 10 mg/ml in 25 mM 
Na2HPO4 pH 8.5 and 200 mM NaCl. The DX protein crystallization condition was 
optimized base on the crystallization condition from previous publication (Simmons et 
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al., 2010). A protein drop with a volume of 1 µl was combined with an equivalent volume 
of reservoir solution containing 150 - 200 mM sodium phosphate (pH 8.5), 500 mM 
sodium citrate, 400 mM sodium chloride and 10 - 25 % v/v PEG 400, without the 
presence of the ATP. The DX crystals have grown within 4 days to 250 microns x 75-100 
microns x 75-100 microns (Figure 6.2).  
 
Figure 6.2. Image of DX protein crystals. 
Data collection and analysis 
 Crystal data was collected at the Arizona State University X-ray diffraction 
facility using Rigaku RAXIS IV++ detector at a wavelength of 1.54 Å. The diffraction 
data were indexed, refined, integrated and scaled using the HKL 2000 package 
(Otwinowski and Minor, 1997). The DX protein crystals diffracted to a resolution limit of 
2.50 Å (Figure 6.3) with the space group P3221, which also share the same space group 
as the previously solved structure (Smith et al., 2007; Simmons et al., 2009; Simmons et 
al., 2010). The cell dimensions were a=b= 72.19 Å, c= 54.82 Å with angles α=β= 90°, γ 
=120°. Total observation and unique reflections were 29,575 and 5,845 respectively. 
Rmerge was 8.5 % with 99.1% completeness. Data are summarized in Table 6.1. 
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Figure 6.3. Image of X-ray diffraction of DX protein. 
Structure refinement 
The DX structure was refined using PHENIX (Adams et al., 2010) with the 
previously solved model (PDB ID: 3DGM) (Simmons et al., 2009). The complete DX 
structure had Rwork and Rfree of 17.31 % and 21.52 %, respectively (Table 6.1). 
Ramachandran plot values of the structure were 98.51 % and 1.49% in preferred and 
allowed regions, respectively, with no outlier. RMSD bond length and bond angle were 
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Table 6.1. Summary of X-ray data and refinement of DX 
Data Collection  
Wavelength (Å) 1.54 
Exposure time (s) 300 
Oscillation range (°) 0.5 
Cell dimensions (Å) a= b= 72.19, c= 54.82 
Angle (°) α=β=90, γ =120 
Space group P3221 
Resolution  (Å) 41.22 - 2.50 
Total Observations  29,575  
Unique reflections 5,845  
Multiplicity 5.0 (4.5) 
I/σ 9.7  
Rmerge (%) 8.5 
Completeness (%) 99.1 (96.0) 
Refinement  
Rwork (%) 17.31 
Rfree (%) 21.52 
RMSD  
    Bond length (Å) 0.003 
    Bond angle (°) 0.931 
Ramachandran plot (%) 
    Favored 98.51 
    Allowed 1.49 
    Outlier  0.00 
R-factor =Σ| |Fobs| -|Fcal||/ Σ |Fobs|, Free R-factor was calculated with setting aside 5% of 
the reflection data. Rmerge = ΣhklΣj |Ij(hkl) – [I(hkl)] | ΣhklΣj[I(hkl)] where Ij(hkl)is the 
intensity reflection, and I(hkl)is the mean intensity of symmetry related h, k, l.  
The three-dimensional structure of DX protein 
The DX protein structure has the same fold, α-helices and β-strands as previously 
reported for the DX structure (Figure 6.1) (Smith et al., 2007; Simmons et al., 2009; 
Simmons et al., 2010). Present are a Zn metal ion coordinated with Cys residues, a PEG 
molecule (Figure 6.4a).   
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Figure 6.4. Three-dimensional structure of DX protein. a). DX structure 
shown in green with the presence of Zn (purple sphere), ATP (right) and 
small molecule PEG (top). The DX consists of three beta strands and two 
alpha helices.  ATP interacts with DX in between bent β-strand and one of 
the α-helices. b). 2Fo-Fc electron density map of ATP.  
 
 The crystallographic data revealed strong electron density of the ATP at the 
binding site. Although ATP was not introduced during purification, a small amount of 
ATP was generated during protein expression and carried through the purification 
process. The presence of ATP shown in the DX structure (Figure 6.4) (this work) 
strongly suggested that it is challenging to obtain a free ATP in DX protein sample. 
Therefore, it is unfeasible to conclude the role of ATP in conformation changes in DX 
protein from this work. To overcome this problem, it would be necessary to chemically 
synthesize the DX protein to avoid ATP inferring due to protein overexpressed in E. coli 
system. Then crystallization and X-ray diffraction of DX could be pursued for the 
conformation change. 
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